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2. THE LIST OF ABBREVIATION 
 
AIM2: absent in melanoma 2 
ALD: alcoholic liver disease 
AP-1: activator protein-1 
ASC: apoptosis-associated speck-like protein containing a caspase recruitment domain 
ATP: adenosine triphosphate 
BSA: bovine serum albumin 
cDNA: complementary deoxyribonucleic acid 
Ctr: control 
DAMP: danger-associated molecular pattern 
dI-dC: poly(deoxyinosinic-deoxycytidylic) acid 
DSS: dextran sodium sulfate 
DTT: dithiothreitol 
EDTA: ethylenediaminetetraacetic acid 
ELISA: enzyme-linked immunosorbent assay 
EMSA: electrophoretic mobility shift assay 
EtOH: Lieber-DeCarli ethanol diet 
FBS: fetal bovine serum 
GFAP: glial fibrillary acidic protein 
HEPES: 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HMGB1: high-mobility group box-1 
HRP: horseradish peroxidase 
Iba1: ionized calcium-binding adaptor molecule-1 
IBD: inflammatory bowel disease 
IL: interleukin 
IL-1R: IL-1 receptor 
IL-1Ra: IL-1R antagonist 
IP: immunoprecipitation 
i.p.: intraperitoneal 
KCl: potassium chloride 
KO: knockout 
DOI:10.14753/SE.2016.1906
 5 
LPS: lipopolysaccharide, endotoxin 
LRR: leucine-rich repeat 
MCP-1: monocyte chemotactic protein-1 
miRNA: micro-RNA 
mRNA: messenger RNA 
MyD88: myeloid differentiation primary response gene (88) 
Na3VO4: sodium orthovanadate 
Na4P2O7: sodium pyrophosphate decahydrate 
NACHT: NAIP (neuronal apoptosis inhibitor protein), C2TA (major histocompatibility 
complex class 2 transcription activator), HET-E (incompatibility locus protein 
from Podospora anserina) and TP1 (telomerase-associated protein) 
NaF: sodium fluoride 
NF-κB: nuclear factor-κB 
NLRP1: NACHT, LRR and PYD domains-containing protein-1 
NLRP3: NACHT, LRR and PYD domains-containing protein-3 
NLRP6: nucleotide-binding oligomerization domain-like receptor-6 
NLRC4: nucleotide-binding oligomerization-like receptor family caspase recruitment 
domain-containing protein 4 
PAMP: pathogen associated molecular patterns 
PBS: phosphate buffered saline 
PMSF: phenylmethylsulfonyl fluoride 
PSC: primary sclerosing cholangitis 
PRR: pattern recognition receptor 
PYD: pyrin domain 
RAGE: receptor for advanced glycation end products 
Reg3b: regenerating islet-derived protein III-β 
RIPA: radioimmunoprecipitation assay 
RNA: ribonucleic acid 
rIL-1Ra: recombinant IL-1Ra 
ROS: reactive oxygen species 
SEM: standard error of the mean 
TBS: tris buffered saline 
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TLR: Toll-like receptor 
TNFα: tumor necrosis factor-α 
UC: ulcerative colitis 
v/v: volume per volume 
WHO: World Health Organization 
WT: wild type 
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3. INTRODUCTION 
 
3.1. Burden of alcohol-related diseases 
Based on a WHO report from 2012, 5.9% of all global deaths (3.3 million) were 
attributable to alcohol consumption [1]. Globally, harmful use of alcohol has been 
ranked among the top five risk factors for diseases and death [2]. Alcohol consumption 
is associated with the risk of developing a range of health problems including 
neuropsychiatric conditions (i.e. alcohol dependence), gastrointestinal diseases (liver 
cirrhosis), malignancies (colorectal cancers), cardiovascular diseases (hemorrhagic 
stroke), pre-term birth complications, and injuries (such as road accidents) [3]. There is 
an estimate that alcohol use plays a causal role in almost 200 diseases [3]. Furthermore, 
regarding its vastness, international classification of disease (ICD-10) dedicated a code 
for mental and behavioral disorders due to alcohol. The amount of alcohol consumption, 
mainly containing ethanol, the drinking patterns and rarely the quality of alcohol are the 
major determinants of harmful outcome [4]. Worldwide, 13.5 gr/day pure alcohol (equal 
to 6.5 liters) is consumed by drinkers aged 15 and more of which 16% have pattern of 
heavy drinking episodes [4]. There is a large geographical variation in alcohol related 
morbidity, and Europe has the highest alcohol-attributable fraction rate [4]. Based on a 
2010 report, Hungary was categorized among the countries with high consumption of 
alcohol per capita (≥12.5 liters) (Figure 1) [5]. 
 
Figure 1. Total alcohol per capita (15+ years) consumption, in liters of pure alcohol, 2010 [5] 
(Reprinted with permission from publisher’s URL: 
http://gamapserver.who.int/mapLibrary/Files/Maps/Global_consumption_percapita_2010.png; date 
accessed 10-07-2015). 
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There is a gender difference in global death related to alcohol, as an epidemiologic 
study from Hungary in 2003 reported 27.5 and 23.2% casual, 7.7 and 31.3% mild, 2.5 
and 17.7% severe alcohol consumption among female and male, respectively [6]. 
Overall based on a 2010 estimate, prevalence of alcohol use associated diseases and 
dependence in Hungary was 17.7% (31% for male, 6% for female) [7]. Increase in 
alcohol consumption per capita is strongly correlated with increase in alcohol-
attributable deaths [8, 9]. In Hungary in 2010 alcohol-attributable death was 13.3% in 
spite of the decrease from 17.1% in 2005, it is still among the highest (Figure 2) [10]. 
 
Figure 2. World: Proportion of all deaths attributed to alcohol (alcohol-attributable fractions, %; 
all ages), 2012 [10]. (Reprinted with permission from publisher’s URL: 
http://gamapserver.who.int/mapLibrary/Files/Maps/Global_deaths_2012.png; date accessed 10-07-2015). 
 
The first line of treatment is prevention, cessation of alcohol use and proper nutrition. 
However, once alcoholic organ damage has emerged, even abstinence and our limited 
non-specific therapeutic options might be ineffective in preventing progression of the 
disease or death [11]. As a result of easy (even natural) availability, addictive effect and 
harmful consequences of alcohol our effort should focus on finding a safe, effective and 
economically beneficial treatment for alcohol related diseases. In order to achieve a 
refined treatment, understanding the mechanism, cellular and subcellular changes as a 
result of alcohol consumption is crucial. 
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3.2. Effects of alcohol 
3.2.1. General 
Long term use of alcohol generally affects major organ systems – digestive-, 
circulatory-, nervous-, endocrine-, immune system, etc. The effects include 
inflammatory changes and carcinogenesis. Furthermore alcohol intake affects the next 
generation as prevalence of fetal alcohol spectrum disorder as a result of parental 
alcohol intake is around 1% [12]. 
The impact of alcohol is not limited to the increased incidence of certain disease, it also 
affects the course and outcome of other diseases. The mechanism by which alcohol 
harms organs and tissues is not thoroughly understood, its range varies from direct 
irritation, conversion to other toxic agents such as acetaldehyde, induction of 
inflammatory by-products, acting as solvent for other toxic agents, slowing the 
detoxification of other processes, lowering level of nutrients (such as folate) to 
completely unknown pathways [13]. 
 
3.2.2 Intestine 
During alcohol ingestion the oral mucosa, esophagus, stomach and small intestine are 
exposed to high concentrations of alcohol [14], which leads to the most severe direct 
and pure effect of alcohol seen among organs. Alcohol impairs the gastrointestinal 
barrier function by inducing inflammation, epithelial cell apoptosis and necrosis [14-
18]. Furthermore, bacterial overgrowth, decreased antimicrobial peptide level and 
impaired epithelial tight junction is associated with chronic alcohol use in the proximal 
small intestine [19-21]. Affected intestinal barrier allows systemic translocation of 
pathogen- or danger-associated molecular patterns (PAMPs or DAMPs) [22]. PAMPs 
and DAMPs activate pro-inflammatory pathways via pattern-recognition receptors 
(PRRs) [22]. The increased amount of bacterial cell wall, endotoxin / 
lipopolysaccharide (LPS), in the serum is suggestive of impaired gut barrier function, 
which is observed in animal models of alcoholism as well as patients with chronic 
alcohol use [23, 24].  
Inflammation might occur within the intestinal wall following the loss of barrier 
integrity, or as a direct effect of alcohol, which could then contribute to further loss of 
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function. Duodenal inflammation is observed in alcoholic individuals, including 
increased presence of B lymphocytes [15, 25]. 
Nuclear factor-κB (NF-κB) activation and as a consequence tumor necrosis alpha 
(TNFα) production has been suggested to be part of the pathogenesis of intestinal 
inflammatory processes [26, 27]. Supporting this theory, dysbiosis-induced intestinal 
inflammation causes loss of barrier function via TNFα receptor which then leads to 
alcoholic liver disease in mice [28]. 
Inflammatory cytokine, interleukin-1β (IL-1β), produced by macrophages, contributes 
to immune tolerance of the intestine via regulating expansion of regulatory T cells 
through macrophages and dendritic cells [29]. Additionally, NF-κB pathway mediated 
IL-1β release is associated with increased permeability in Caco2 cell line [30]. 
Inflammasome activation occurs in dextran sodium sulfate (DSS) induced colitis model 
in mice and is observed to contribute to the healing process of the intestinal barrier via 
the maturation of IL-18 which is similarly produced to IL-1β [31]. 
So far there is no clear data on inflammasome activation, IL-1β or TNFα production or 
their possible role in alcohol induced inflammatory changes in the small intestine. 
 
3.2.3. Liver 
Alcohol and alcohol-induced P/DAMPs have easy access to hepatocytes, stellate and 
Kupffer cells in the liver because the sinusoids do not form a strong barrier. The major 
metabolism of alcohol occurs in the liver, therefore the cellular effects of harmful 
derivates, including acetaldehyde is mainly expected in the liver of alcoholics [32]. 
Consequences follow as chronic alcohol intake frequently induces steatohepatitis, 
cirrhosis and can result in hepatic cancer. The most common feature, steatohepatitis 
consists of fatty transformation and inflammatory changes [33]. Both Kupffer cells and 
hepatocytes are involved in the process of alcohol-induced inflammation where excess 
pro-inflammatory cytokine (TNFα and IL-1β) production is observed [34]. Chronic 
alcohol use induces hepatocyte apoptosis and necrosis [35], which can facilitate the 
inflammatory changes. Furthermore, long-term alcohol exposure-induced inflammation 
is associated with fibrotic changes of the liver mediated by stellate cells [34]. Fibrosis 
and chronic inflammation is associated with increased risk of hepatocellular carcinoma 
formation [36]. Cellular changes, inflammasome activation, pro-inflammatory cytokine 
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secretion, reactive oxygen species (ROS) production, apoptosis, changes in micro-RNA 
(miRNA) expression are all part of the underlying mechanism [34, 37, 38]. 
 
3.2.4. Brain 
Alcohol can easily pass through the blood-brain barrier, including the endothelial sheet 
as well as the astrocyte wrap due to its small size and lipophilic property [39]. Neural 
cell apoptosis, defective neuroregeneration, microglia- and astrocyte activation are some 
of the cellular hallmarks of alcohol induced changes in the brain [40-44]. Primarily 
alcohol alters behavior via changes in neurotransmission, further alcoholism leads to 
dementia, ataxia via neurodegeneration and possibly neuroinflammation, which are 
mediated by innate immune responses [45, 46]. Long-term alcohol intake results in 
neuroinflammation and neurodegeneration both in human and animals [43, 44, 47, 48]. 
Chronic alcohol ingestion increases expression of monocyte chemotactic protein-1 
(MCP-1), TNFα, and caspase-3 in the brain [43, 44, 47]. Inflammatory cytokines affect 
neurons and are associated with disease symptoms [49]. Toll-like receptor-4 (TLR4) 
signaling pathway plays an important role in the alcohol-induced production of 
inflammatory cytokines in different regions of the brain [46]. Cellular changes, pro-
inflammatory cytokine secretion, ROS production, apoptosis, changes in miRNA 
expression are all part of the underlying mechanism of alcohol induced 
neuroinflammation and -degeneration. 
Cerebellum although affected by alcohol consumption [50], there is no clear data on 
inflammasome activation, IL-1β or TNFα production or their possible role in alcohol 
induced inflammatory changes in this brain region. 
 
3.3. Intestine-liver-brain axis 
3.3.1. General considerations 
The portal circulation and the biliary system makes the interaction between intestine and 
the liver bidirectionally strong. Circulation makes an easy channel to communicate 
between organs. Peripheral nervous system allows the brain to receive and act fast using 
neural reflexes. 
The significance of gut-liver interaction is suggested by the evidences that hepatobiliary 
involvement in inflammatory bowel disease (IBD) is high; 70-80% of primary 
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sclerosing cholangitis (PSC) patients have ulcerative colitis (UC) [51]; alcoholic liver 
disease (ALD) patients have leaky gut and endotoxemia [52]; the altered intestinal 
microbiome is associated with various liver diseases [53]. 
 
Figure 3. Intestine-liver-brain axis. Most harmful agents enter via the GI system, skin or lung and are 
distributed through systemic and/or lymph circulation inducing inflammation in different organs 
including the entering site. The harmful agents can go through first-pass metabolism in the liver and in 
original or metabolite form can be excreted to the bile entering the intestinal system. Similarly, but to a 
lesser extent kidney/lung/skin/GI tract, etc. have excretory ability. Neural reflexes quickly deliver signals 
to the brain and back to the organs, fast responding to the problem. DAMPs and cytokines induced in the 
inflammatory process can enhance inflammation at the site of origin or can use similar pathways to 
PAMPs and reach other organs to affect. 
 
The involvement of brain in disease condition results in altered behavior, fatigue, 
anorexia, loss of appetite, occasionally fever which are caused by the circulating 
PAMPs and DAMPs including cytokines like TNFα and IL-1β of the affected organ, 
whereas others are results of direct neuronal interactions [54, 55]. Motor and secretory 
function of intestine or neutrophil accumulation of the liver can all be affected [54-57]. 
Consecutively the overall performance of the individual changes [54-57]. Emerging 
evidences suggest that intestinal-brain interactions play crucial role in the pathogenesis 
of IBS and IBD [58]. Chronic intestinal inflammation in mice reduces hippocampal 
neurogenesis [40]. LPS has an indirect role in neuroinflammation, as neuroimmune 
reflexes can sense and respond to peripheral injuries [49]. Moreover vagotomy 
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diminishes IL-1β response in the brain, but not on the periphery after intraperitoneal 
injection with LPS [59]. Inflammatory cytokine TNFα is rapidly induced and remains 
elevated for a prolonged period of time in the brain after peripheral LPS challenge [60]. 
Serum radiolabeled TNFα is being transported through the blood-brain barrier via 
endothelial receptors in a saturable manner [61]. Furthermore, LPS-induced 
intracerebral IL-6 signaling inhibits neurogenesis in the hippocampus [41]. 
This finely tuned live system, the intestine-liver-brain axis has a lot of possible 
connection routes (Figure 3). 
 
3.3.2. Alcohol effects 
Alcoholic individuals have altered and increased bacterial load in their intestine [21]. 
Bacterial endotoxin LPS seeping through alcohol-disrupted barrier of the intestine is 
increased in the sera of alcoholics [14-18, 23, 62, 63]. LPS contributes to alcoholic liver 
disease and therefore DAMP secretion from liver [62]. Reversing dysbiosis by certain 
antibiotics, probiotics or long-chain fatty acids can restore intestinal barrier function and 
decrease the subsequent liver damage [28, 64-66]. Intestinal mucus is increased in rats 
after alcohol feeding and mucin-2 deficiency can ameliorate alcoholic liver disease in 
mice [67, 68], which further underlines the importance of every aspect of the intestinal 
barrier.  
The pro-inflamatory cytokines, PAMPs and DAMPs originating from the intestine 
enhance the inflammatory changes in other organs, including liver and brain via direct 
and indirect effects. Liver is a source of excessive inflammatory cytokine production in 
alcoholics which are released to the serum, as a response to alcohol and its toxic 
metabolites, as well as PAMPs and DAMPs originating from the intestine [69]. Both 
primary and secondary bile acids are increased in alcoholics and are currently suggested 
to play a role in the pathogenesis of colonic inflammation [70].  
Brain damage is more common among alcoholics with cirrhosis and liver-failure than 
without liver disease [71]. High ammonia level is widely known for its neurotoxic 
effect, and can activate peripheral benzodiazepine receptors, contributing to astrocyte 
swelling and subsequent coma [72]. As a reverse interaction, intracerebral IL-1β 
injection results in hepatic recruitment of neutrophils [57]. It is noteworthy that alcohol 
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induces cortisol secretion modifying the immune system as part of the neuroimmune 
pathology [56]. 
The signaling and regulatory pathways might be similar to regulate gene expression in 
different organs, as there are similarities in gene expression profiles induced by alcohol 
in astrocytes and hepatocytes [34, 73, 74]. 
 
3.4. Inflammasome 
Innate immune signaling pathways are hallmarks of alcohol-induced organ damage 
affecting intestine, liver, cardiovascular system, and brain [43, 69, 75]. Inflammation 
and these altered innate immune responses play pivotal roles in the pathogenesis of 
infectious and degenerative disorders [76, 77]. Part of these pro-inflammmatory 
changes, inflammatory cytokines and mediators including IL-1β, TNFα, high-mobility 
group protein-B1 (HMGB1) affect neurons and are associated with disease symptoms in 
animal models [49]. 
 
Figure 4. Inflammasome signaling [template [78] with some alterations]. 
 
Increased level of the inflammatory cytokine, IL-1β is found in the sera of alcoholics 
[79] and in brains and livers of rodents after alcohol intake [43, 80]. The inactive form 
of IL-1β, pro-IL-1β level is increased in response to PRR including TLR activation 
upon endogenous or exogenous danger signals [81].  Following activation of the 
receptors, inflammasome processes pro-IL-1 to mature, active IL-1 via caspase-1 
activation [81]. Inflammasomes are multi-protein complexes mostly containing NOD-
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like receptors (NLRs: NLRP1, NLRP3, NLRC4); an adapter molecule, ASC; and 
effector pro-caspase-1 [81]. At first, a priming signal, usually an inflammatory stimuli 
upregulate the expression of these inflammasome components and target proteins, pro-
caspase-1 and pro-IL-1β [82]. A second signal is generally required for inflammasome 
activation [82]. Upon inflammasome activation, pro-caspase-1 is converted to caspase-1 
(a proteolytic, effector enzyme) which then cleaves pro-IL-1β to IL-1β, the bioactive, 
secretable form (Figure 4) [81]. 
IL-1β exerts its biologic function via the type I IL-1 receptor (IL-1R) and amplifies 
inflammation through both autocrine and paracrine manner [83]. The endogenous 
inhibitor of IL-1R, IL-1R antagonist (IL-1Ra) occupies the IL-1R without transducing 
activation unlike activators IL-1α and IL-1β (Figure 5) [84]. 
 
Figure 5. Interleukin-1-receptor signaling. 
 
3.4.1. Signal 1. 
PRR activation is needed for inflammatory gene induction [81]. PRR, TLR4 has a 
pivotal role in the pathogenesis of alcohol-induced liver damage and neuroinflammation 
[46, 62]. TLR activation via DAMPs and PAMPs leads to NF-κB activation and 
subsequently increased cytokine production [85]. 
Transcription factor NF-κB activation is involved in the pathogenesis of alcohol-
induced hepatitis and neuroinflammation [45, 86]. NF-κB is known to induce the 
transcription of pro-inflammatory cytokines and chemokines, like TNFα, IL-1β and 
MCP1 [85, 87], all of which are increased in alcohol-induced hepatitis and 
neuroinflammation [34, 45, 46]. NF-κB activation and TNFα production have been 
suggested to play role in the pathogenesis of intestinal inflammatory processes [26, 27]. 
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3.4.2. Signal 2. 
Posttranslational cleavage of pro-IL-1β to mature IL-1 is required for its functional 
activity and is executed by the inflammasome through caspase-1 activation [81]. 
PAMPs or DAMPs in sterile inflammation as a second signal can induce inflammasome 
activation [22]. DAMPs are molecules or cells that, upon cellular danger/damage, are 
actively excreted or passively released [88]. A recently widely recognized DAMP, 
HMGB1 is a nuclear protein that upon cytoplasmic translocation after phosphorylation 
or acetylation represents a danger signal and activates TLRs and the inflammasome 
(Figure 6) [89, 90]. 
 
Figure 6. HMGB1 activation HMGB1 is passively released from damaged cells or as seen here can 
actively be excreted from cells after phosphorylation or acetylation. 
 
Inflammasome activation and IL-1β signaling play a role in various liver diseases 
including acetaminophen injury and non-alcoholic steatohepatitis [91, 92].  
Furthermore, inflammasome activation contributes to the pathogenesis of various 
neurologic disorders including traumatic and thromboembolic brain injury and 
Alzheimer’s disease [93-96].  
The significance of IL-1 signaling and inflammasome activation has not been evaluated 
in alcoholic intestinal, liver and brain injury which became the target of our research 
team, the main focus of this thesis is the effect of alcohol on the proximal small 
intestine and the cerebellum. 
DOI:10.14753/SE.2016.1906
 17 
4. OBJECTIVES 
 
1. To evaluate the inflammasome activation in the proximal intestine of an animal 
model of alcoholism. 
2. To evaluate the inflammasome activation in the cerebellum of an animal model of 
alcoholism. 
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5. METHODS 
 
5.1. Animals 
5.1.1. Ethical approval: These studies were conducted according to the regulations of 
the Institutional Animal Use and Care Committee of the University of Massachusetts 
Medical School (Worcester, MA). 
 
5.1.2. Genotypes: Six to eight weeks old female C57/BL6J wild type (WT); TLR4 
knock-out (KO); apoptosis-associated speck-like protein containing a caspase 
recruitment domain (ASC) KO; NACHT, LRR and PYD domains-containing protein 
3 (NLRP3) KO mice (backcrossed on a C57/BL6J background) were employed. 
 
5.1.3. Diet: The animals on chronic ethanol-regime received 5% (v/v) ethanol (36% 
ethanol-derived calories) containing Lieber-DeCarli diet (EtOH) or pair-fed diet (Ctr) 
with an equal amount of calories where the alcohol-derived calories were substituted 
with dextran-maltose (Bio-Serv, Frenchtown, NJ, USA) for 5 weeks. The daily 
consumption of the diet was the same in the WT and KO mouse strains, approximately 
10ml/animal. The animals had access to water ad libitum and the consumption was 
comparable among the different diet groups.  
The animals on acute ethanol-regime received 5g/kg 50% (v/v) ethanol diluted in water 
or an equal amount of water via oral gavage for three consecutive days (otherwise 
indicated) using a stainless steel 22-gauge feeding tube. 
 
5.1.4. Treatment: Where indicated, WT mice received daily intraperitoneal injection 
(i.p.) of 25 mg/kg recombinant IL-1Ra (anakinra; Amgen) or equal amount of saline 
throughout the whole experiment. 
Some eight weeks old female C57/BL6J mice were anesthetized with Isoflurane, 
inhalation, to effect and received 30μl intracranial (posterior fontanelle) injection with 
recombinant mouse IL-1β (100ng/mouse) (R&D Systems, Inc., Minneapolis, MN) or 
equal amount of saline solution, these animals were sacrificed six hours after the 
procedure. 
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5.1.5. Sample collection and storage: Across the study animals were sacrificed in the 
morning following cheek bleeding. In the acute model this was 6 or 12 hours after the 
last gavage (otherwise indicated) and in the chronic alcohol model at 12 hours after the 
start of the last feeding. The sample collection after chronic feeding in the morning was 
approximately 3-5 hours following the actual end of the final feeding. Animals were 
sacrificed by cervical dislocation. 
Serum was isolated from blood by centrifugation. The proximal third of the small-
intestine was immediately isolated and kept in 2% fetal bovine serum (FBS) containing 
PBS on ice for further processing. Proximal intestines were immediately flushed with 
cold PBS, dissected longitudinally, washed further in PBS, until intestinal content was 
removed. Peyer patches were dissected and discarded. The 1st and the 3rd-6th cm of the 
proximal intestine were snap frozen in liquid nitrogen for protein evaluation. The 2nd 
cm was incubated in RNAlater (Qiagen, Hilden, Germany) at 4°C overnight for RNA 
extraction. Cerebella and cerebra were immediately isolated and were snap frozen or 
stored in RNAlater. All samples were stored at -80°C. 
 
5.2. Laboratory methods 
5.2.1. Alcohol concentration: Blood alcohol content in serum was measured using 
alcohol analyzer (Analox Instruments, Lunenburg, MA, USA). 
 
5.2.2. Quantitative polymerase chain reaction (qPCR): RNA was extracted from the 
2nd cm of proximal small-intestine, cerebellum or cerebrum using RNeasy kit (Qiagen, 
Maryland, USA). Optical density (260/280 and 260/230 ratios) was measured to check 
RNA quality. cDNA was transcribed from 1ug of total RNA by using Reverse 
Transcription System (Promega Corp., Madison, Wisconsin, USA) in a final volume of 
30ul. Sybr-Green-based real-time quantitative PCR was performed using the iCycler 
(Bio-Rad Laboratories Inc., Hercules, California, USA). Each 25ul reaction contained 
200nM of primer mix (1/1, v/v) and 2.5ul of diluted (1/4, v/v) cDNA. Primers used for 
the experiments are listed in Table 1. The PCR contained a denaturation step for 3 min 
at 95°C and 45 cycles of 30s at 95°C, 45s at gene-specific annealing temperature and 
30s at 72°C for primer extension. MicroAmp optical 96-well reaction plate with optical 
tape was used for all amplifications and detections. The increase in fluorescence by 
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double-stranded DNA-binding Sybr-Green was detected each cycle, indicating PCR 
product accumulation. A dissociation melting curve was performed between 55 and 
95°C. Comparative threshold cycle (ΔΔCt) method was used to calculate expressions 
relative to WT control groups. Ct for the target amplicon and the internal control, 18S 
gene, were determined. All results were normalized to their own internal control 18S to 
remove the differences in the amounts of nucleic acid added due to any deficiency of 
the reverse transcriptase PCR step (ΔCt), the values were then normalized to the 
average of the actual reference control sample group (ΔΔCt). The final results were 
expressed as fold changes (2-ΔΔCt) between the sample and the controls corrected with 
18S. 
 
Table 1. Real-Time PCR Primers – forward and reverse sequence of the primers used in real-time PCR. 
TARGET GENE FORWARD PRIMER (5'>3') REVERSE PRIMER (5'>3') 
18S GTA ACC CGT TGA ACC CCA TT  CCA TCC AAT CGG TAG TAG CG 
ASC GAA GCT GCT GAC AGT GCA AC GCC ACA GCT CCA GAC TCT TC  
HMGB1 CGC GGA GGA AAA TCA ACT AA  TCA TAA CGA GCC TTG TCA GC 
IL-1R GCC CAC CTA GAA GGG CGG GA CCA GCG ACA GCA GAG GCA CC 
IL-1Ra GAG ACA GCC TGC CTG CCT GGG GGA TCA CTG GCA TGG CCA CCT GC 
NLRP1 TGG CAC ATC CTA GGG AAA TC  TCC TCA CGT GAC AGC AGA AC 
NLRP3 AGC CTT CCA GGA TCC TCT TC  CTT GGG CAG CAG TTT CTT TC  
NLRP6 CAGAAGGGCAAGCAAAAGAC ACATTCAGCAACACGCTCAG 
Pro-caspase-1 AGA TGG CAC ATT TCC AGG AC GAT CCT CCA GCA GCA ACT TC  
Pro-IL-1β TCT TTG AAG TTG ACG GAC CC TGA GTG ATA CTG CCT GCC TG  
RAGE GAA GGC TCT GTG GGT GAG TC  CCG CTT CCT CTG ACT GAT TC  
Reg3b TAC TGC CTT AGA CCG TGC TTT CTG GAC ATA GGG CAA CTT CAC CTC ACA 
TLR2 ACA ATA GAG GGA GAC GCC TTT  AGT GTC TGG TAA GGA TTT CCC AT 
TLR4 GCC TTT CAG GGA ATT AAG CTC C AGA TCA ACC GAT GGA CGT GTA A 
TLR9 TGA AGT CTG TAC CCC GTT TCT  GTG GAC GAA GTC GGA GTT GT  
TNFα CAC CAC CAT CAA GGA CTC AA  AGG CAA CCT GAC CAC TCT CC 
 
5.2.3. Electrophoretic mobility shift assay (EMSA): End labeling of double-stranded 
NF-κB oligonucleotide,  5’AGTTGAGGGGACTTTCGC3’ was accomplished by 
treatment with T4 polynucleotide kinase in the presence of γ32P-ATP (PerkinElmer, 
Waltham, MA), followed by purification on a polyacrylamide copolymer column (Bio-
Rad). Proximal intestinal or cerebellar whole cell lysates (5μg) were incubated with 1μl 
labeled oligonucleotide (50,000 cpm), 4μl dI-dC (Affymetrix Inc., Santa Clara, CA) and 
5X gel buffer (containing 20mM HEPES pH7.9 (Sigma, St. Louis, MO), 50mM KCl 
(Sigma, St. Louis, MO), 0.1mM EDTA (Boston BioProducts Inc., Ashland, MA), 1mM 
DTT (Sigma, St. Louis, MO), 5% glycerol (Fisher Scientific, Fair Lawn, NJ), 200 g/ml 
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BSA in sterile water). A 20 μl final volume was reached by adding nuclease-free water. 
For cold competition reaction a 20-fold excess of specific unlabeled double-stranded 
probe was added to the reaction mixture 20 minutes prior to adding the labeled 
oligonucleotide. Samples were incubated at room temperature for 20 minutes. Reactions 
were run on a 4% polyacrylamide gel. Gels were then dried and exposed to an X-ray 
film at -80°C for 6 hours or overnight where appropriate. Kodak X-OMAT 2000A 
Processor was used for film development in the darkroom. The films were scanned and 
densitometry was performed on the images using Multi Gauge Ver.3.2 image software 
(Fujifilm Corp., USA). 
 
5.2.4. Enzyme-linked immunosorbent assay (ELISA): Tissue lysates were prepared from 
proximal intestines, cerebella and cerebra in RIPA buffer containing protease and 
phosphatase inhibitors (1mM PMSF, 1mM NaF, 2mM Na3VO4, 20mM Na4P2O7, 
protease and phosphatase inhibitor tablet). First, the tissue was homogenized with 
stainless steel bead (Qiagen, Maryland, USA) in TissueLyser II (Qiagen, Maryland, 
USA) then clarified by centrifugation. The tissue lysate supernatant was stored at -80°C. 
Protein level was measured by ELISA reader using Bio-Rad protein assay dye reagent 
concentrate (Bio-Rad Laboratories Inc., Hercules, CA). TNFα (BD Biosciences, San 
Diego, CA) and IL-1β (R&D Systems, Inc., Minneapolis, MN) were measured in whole 
tissue lysates using specific anti-mouse ELISAs. 
 
5.2.5. Enzyme-activity assay: Caspase-1 colorimetric assay was used to determine the 
enzymatic activity (R&D Systems, Inc., Minneapolis, MN) from cerebellar and cerebral 
tissue lysates. It has been shown earlier that the results of caspase-1 activity assay 
correspond to the Western blot results of cleaved capase-1 p10 protein in liver [34], we 
further evaluated the method for brain tissue using Western blots (Figure 15E-F). 
 
5.2.6. Endotoxin: Endotoxin levels were evaluated in serum and cerebellar lysates with 
Limulus Amebocyte Lysate assay (Lonza Group Ltd, Basel, Switzerland). 
 
5.2.7. Western blot: Equal amounts of protein from tissue lysates were run on 15% 
polyacrylamide gel. Proteins were transferred to nitrocellulose membrane overnight 
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then blocked for two hours in blocking buffer-1 or 2. Primary antibodies against mouse 
Reg3b (R&D Systems Inc., Minnesota, USA), IL-1β (R&D Systems, Inc., Minneapolis, 
MN), caspase-1 p10 (Santa Cruz Biotechnology Inc., Santa Cruz, CA), HMGB1 
(Abcam, Cambridge, MA), and beta-actin (Abcam, Cambridge, MA) were used 
overnight at 4˚C at different dilution rates varying from 1:100 to 1:30,000 in blocking 
buffer-1 or 2, followed by three washing steps. For detection, appropriate donkey anti-
sheep, goat anti-rat, anti-rabbit or anti-mouse secondary horseradish peroxidase–labeled 
secondary antibodies (Santa Cruz Biotechnology Inc., Santa Cruz, CA) were used for 
one hour at a dilution rate of 1:5000 in blocking buffer-1 or 2. The immunoreactive 
bands of interest were detected by chemiluminescence using Pierce ECL Western 
blotting substrate (Pierce Biotechnology, Rockford, IL) and LAS-4000IR Ver.2.02 
(Fujifilm Corp., USA) for image acquisition. The results were quantified by 
densitometry analysis using Multi Gauge Ver.3.2 image software (Fujifilm Corp., 
USA).  Blocking buffer-1: 0.1% TWEEN-20 TBS 5% milk. Blocking buffer-2: 0.1% 
TWEEN-20 TBS 5% BSA. 
 
5.2.8. Immunoprecipitation: Equal amounts of proteins from cerebellar tissue lysates 
were pre-cleaned with anti-rabbit Ig IP beads (eBioscience, Inc., San Diego, CA). Beads 
were removed by centrifuge and supernatants were incubated and rotated overnight at 
4˚C with 5 g anti-HMGB1 or anti-acetyl lysine Ab (Abcam, Cambridge, MA) or 
normal rabbit IgG (Santa Cruz Biotechnology Inc., Santa Cruz, CA) as a negative 
control. Samples were partially rotated for one hour with anti-rabbit Ig IP beads at 4˚C. 
The formed immune complexes were collected by centrifugation, washed three times 
and boiled with 2X Laemmli’s sodium dodecyl sulfate-sample buffer (Boston 
BioProducts, Ashland, MA) to dissociate from the beads. The beads were then removed 
by centrifugation. Protein was separated from the supernatants by polyacrylamide gel 
electrophoresis. Proteins were transferred to nitrocellulose membrane and blocked for 
two hours in blocking buffer-2 or TBS with 3% BSA, 0.1% gelatin and 0.2% TWEEN-
20. The membrane was incubated overnight at 4˚C with 3 g/ml anti-phosphoserine or 1 
g/ml anti-HMGB1 Ab (Abcam, Cambridge, MA) in blocking buffer-2 or 3. The 
membrane was washed three times and incubated for an hour with HRP-conjugated 
secondary anti-rabbit IgG Ab (eBioscience, Inc., San Diego, CA) at 1:5000 dilution in 
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blocking buffer-2 or 3. The immunoreactive bands were detected by chemiluminescence 
using Pierce ECL Western blotting substrate and LAS-4000IR. The results were 
quantified by densitometry using Multi Gauge Ver.3.2 image software. The loading 
control was detected on a separate gel by monoclonal mouse anti-beta-actin. Blocking 
buffer-3: 0.2% TWEEN-20 TBS containing 0.5% BSA. 
 
5.3. Statistical analysis: 
Since data was not normally distributed, statistical analysis was performed using 
Kruskal-Wallis nonparametric test. Data are shown as average ± standard error of the 
mean (SEM). Differences were considered statistically significant at P value ≤ 0.05. 
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6. RESULTS 
6.1. Proximal small intestine 
6.1.1. Serum alcohol content in alcohol-fed mice 
Mice receiving either one-time alcohol gavage (Figure 7A) or 5 weeks of alcohol 
feeding (Figure 7B) have significantly higher blood alcohol content than their 
appropriate controls. 
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Figure 7. Serum alcohol content in alcohol-fed mice. Wild type (WT; n=6 or 7) mice were fed with 
ethanol (EtOH) or isocaloric (Ctr) diet for 5 weeks, or had a single oral gavage of 50% 5g/kg ethanol 
(WT; n=6) where blood was collected 30 or 60min after. Blood alcohol content in serum was measured 
using alcohol analyzer (A-B). Bars represent mean±SEM (*: P value<0.05 relative to appropriate 
isocaloric or 0min controls, respectively, by Kruskal-Wallis non-parametric test). 
 
6.1.2. Serum-endotoxin level in alcohol-fed mice 
Mice receiving either three days alcohol gavage (Figure 8A) or 5 weeks of alcohol 
feeding (Figure 8B) have significantly higher serum-endotoxin levels than their 
appropriate controls. Twelve hours after alcohol gavage, no difference of serum-
endotoxin level is found between alcohol gavage and control groups (Figure 8A). 
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Figure 8. Serum-endotoxin level in alcohol-fed mice. Wild type mice were gavaged daily 50% 5g/kg 
ethanol (EtOH; n=6) or equal amount of saline (Ctr; n=6) for three consecutive days or were fed with 5% 
ethanol containing (EtOH; n=8) or isocaloric (Ctr; n=7) diet for 5 weeks. Serum-endotoxin measurement 
was executed using Limulus Amebocyte Lysate-assay (A-B). Bars represent mean±SEM (*: P value<0.05 
relative to appropriate controls by Kruskal-Wallis non-parametric test). 
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6.1.3. Intestinal antimicrobial protein expression in alcohol-fed mice 
Both mRNA (Figure 9A) as well as protein level (Figure 9C, E) of Reg3b is 
significantly higher in the small intestine of mice receiving alcohol gavage than their 
controls. 
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Figure 9. Intestinal antimicrobial protein expression in alcohol-fed mice. Wild type mice were 
gavaged daily 50% 5g/kg ethanol (EtOH; n=6) or equal amount of saline (Ctr; n=6) for three consecutive 
days or were fed with 5% ethanol containing (EtOH; n=8) or isocaloric (Ctr; n=7) diet for 5 weeks. 
Regenerating islet-derived protein III-beta (Reg3b) mRNA was assessed by qRT-PCR in proximal small 
intestine using 18S internal control (A-B). Reg3b protein in whole SB lysates was assessed by Western 
blot using β-actin loading control (C-D), and further quantified by densitometry (E-F). Bars represent 
mean±SEM (*: P value<0.05 relative to appropriate controls by Kruskal-Wallis non-parametric test). 
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In contrast, the expression of Reg3b in the small intestine of chronic alcohol-fed mice is 
significantly lower both at mRNA (Figure 9B) as well as protein level compared to 
controls (Figure 9D, F). (Average; SEM of density values of saline vs. alcohol gavage 
248; 98 vs. 1226; 426 and PF vs. EtOH-feeding [longer exposure] 265; 20 vs. 107; 31, 
respectively). 
 
6.1.4. Intestinal NF-κB activation in alcohol-fed mice 
Both alcohol gavage and chronic alcohol feeding results in significantly higher NF-κB 
activation and DNA binding in proximal small intestine of mice compared to controls 
(Figure 10A-D). The magnitude of increase is significantly greater in mice with chronic 
compared to acute binge alcohol administration. 
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Figure 10. Intestinal NF-κB activation in alcohol-fed mice. Wild type mice were gavaged daily 50% 
5g/kg ethanol (EtOH; n=6) or equal amount of saline (Ctr; n=6) for three consecutive days or were fed 
with 5% ethanol containing (EtOH; n=8) or isocaloric (Ctr; n=7) diet for 5 weeks. Nuclear factor-κB (NF-
κB) activation of whole proximal small intestinal lysates was assessed by EMSA (A-B), loading equal 
amounts of protein, using EtOH-fed intestinal sample for cold competition control (cold ctr), and further 
quantified by densitometry (C-D). Bars represent mean±SEM (*: P value<0.05 relative to appropriate 
controls by Kruskal-Wallis non-parametric test). 
 
6.1.5. Intestinal TNFα level in alcohol-fed mice 
TNFα mRNA levels are significantly higher in the proximal small intestine of mice after 
both acute binge and chronic alcohol feeding compared to controls (Figure 11A-B). 
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However, murine proximal small intestinal TNFα protein levels are significantly higher 
after chronic alcohol feeding (Figure 11D), no difference of TNFα protein level is found 
between alcohol gavage and control groups (Figure 11C). 
A
0 .0
0 .5
1 .0
1 .5
2 .0
T N F   m R N A  P ro x im a l In te s t in e
3  d a y s  g a v a g e
m
R
N
A
 (
fo
ld
 c
h
a
n
g
e
)
*
E tO H
C tr
                            B
0 .0
0 .5
1 .0
1 .5
2 .0
T N F   m R N A  P ro x im a l In te s t in e
5  w e e k s  fe e d in g
m
R
N
A
 (
fo
ld
 c
h
a
n
g
e
) * E tO H
C tr
 
 
C
0 .0
0 .5
1 .0
1 .5
T N F   P ro te in  P ro x im a l In te s t in e
3  d a y s  g a v a g e
T
N
F

 (
fo
ld
 c
h
a
n
g
e
)
N S
E tO H
C tr
                        D
0 .0
0 .5
1 .0
1 .5
2 .0
T N F   P ro te in  P ro x im a l In te s t in e
5  w e e k s  fe e d in g
T
N
F

 (
fo
ld
 c
h
a
n
g
e
)
* E tO H
C tr
 
Figure 11. Intestinal TNFα level in alcohol-fed mice. Wild type mice were gavaged daily 50% 5g/kg 
ethanol (EtOH; n=6) or equal amount of saline (Ctr; n=6) for three consecutive days or were fed with 5% 
ethanol containing (EtOH; n=8) or isocaloric (Ctr; n=7) diet for 5 weeks. Tumor necrosis factor-α (TNFα) 
mRNA was assessed by qRT-PCR in proximal small intestine using 18S internal control (A-B). TNFα 
protein in whole proximal small intestinal lysates was assessed by specific ELISA (C-D). Bars represent 
mean±SEM (*: P value<0.05; NS: not significant; relative to appropriate controls by Kruskal-Wallis non-
parametric test). 
 
6.1.6. Intestinal IL-1β level in alcohol-fed mice 
No difference of murine proximal intestinal pro-IL-1β mRNA (Figure 12A-B) or IL-1β 
protein (Figure 12C-D) level is found between either alcohol gavage or chronic alcohol-
feeding and appropriate control groups [unpublished data]. 
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Figure 11. Intestinal IL-1β level in alcohol-fed mice [unpublished data]. Wild type mice were 
gavaged daily 50% 5g/kg ethanol (EtOH; n=6) or equal amount of saline (Ctr; n=6) for three consecutive 
days or were fed with 5% ethanol containing (EtOH; n=8) or isocaloric (Ctr; n=7) diet for 5 weeks. Pro-
interleukin-β (pro-IL-1β) mRNA was assessed by qRT-PCR in proximal small intestine using 18S 
internal control (A-B). IL-1β protein in whole proximal small intestinal lysates was assessed by specific 
ELISA (C-D). Bars represent mean±SEM (NS: not significant relative to appropriate controls by Kruskal-
Wallis non-parametric test). 
 
6.1.7. Intestinal inflammasome expression in alcohol-fed mice 
No difference of murine proximal small intestinal NLRP3, NLRP6, ASC and pro-
caspase-1 mRNA is found between either alcohol gavage (Figure 12A) or chronic 
alcohol-feeding (Figure 12B) and appropriate control groups [unpublished data]. 
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Figure 12. Intestinal inflammasome expression in alcohol-fed mice [unpublished data]. Wild type 
mice were gavaged daily 50% 5g/kg ethanol (EtOH; n=6) or equal amount of saline (Ctr; n=6) for three 
consecutive days or were fed with 5% ethanol containing (EtOH; n=8) or isocaloric (Ctr; n=7) diet for 5 
weeks. Inflammasome sensors (NLRP3 and NLRP6), inflammasome adaptor (ASC) and inflammasome 
effector (pro-caspase-1) mRNA was assessed by qRT-PCR in proximal small intestine using 18S internal 
control (A-B). Bars represent mean±SEM (NS: not significant relative to appropriate controls by Kruskal-
Wallis non-parametric test). 
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Figure 13. Cerebellar NF-κB activation in chronic alcohol-fed mice. Wild type mice were gavaged 
daily 50% 5g/kg ethanol (EtOH; n=6) or equal amount of saline (Ctr; n=5) for three consecutive days or 
were fed with 5% ethanol containing (EtOH; n=8) or isocaloric (Ctr; n=7) diet for 5 weeks. Nuclear 
factor- κB (NF-κB) activation of whole cerebellar lysates was assessed by EMSA (A), loading equal 
amounts of protein, using EtOH-fed cerebellar sample for cold competition control (cold ctr), and further 
quantified by densitometry (B). Bars represent mean±SEM (*: P value<0.05 relative to appropriate 
controls by Kruskal-Wallis non-parametric test). 
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6.2.1. Cerebellar NF-κB activation in chronic alcohol-fed mice 
Chronic alcohol feeding results in significantly higher NF-κB activation in cerebella of 
mice compared to controls (Figure 13A-B). 
 
6.2.2. Cerebellar TNFα level in chronic alcohol-fed mice 
Both TNFα mRNA (Figure 14A) and protein (Figure 14B) levels are significantly 
higher in the cerebella of chronic alcohol-fed than control mice. 
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Figure 14. Cerebellar TNFα level in chronic alcohol-fed mice. Wild type mice were fed with 5% 
ethanol containing (EtOH; n=6) or isocaloric (Ctr; n=8) diet for 5 weeks. Tumor necrosis factor-α (TNFα) 
mRNA was assessed by qRT-PCR in cerebellum using 18S internal control (A). TNFα protein in whole 
cerebellar lysates was assessed by specific ELISA (B). Bars represent mean±SEM (*: P value<0.05 
relative to appropriate controls by Kruskal-Wallis non-parametric test). 
 
6.2.3. Cerebellar IL-1β level in chronic alcohol-fed mice 
Pro-IL-1β mRNA (Figure 15A) as well as protein (Figure 15C) levels are significantly 
higher in the cerebella of mice after chronic alcohol feeding compared to controls. 
Similar to cerebellar IL-1β protein levels detected by specific ELISA (Figure 15C), 
Western blot result shows significantly higher mature IL-1β protein levels in the 
cerebellum of chronic alcohol-fed compared to control mice (Figure 15E-F). Both pro-
IL-1β mRNA (Figure 15B) and IL-1β protein (Figure 15D) are significantly higher in 
the cerebral cortex of chronic alcohol-fed compared to control mice. The magnitude of 
IL-1β protein increase does not differ between murine cerebellar and cerebral cortex 
upon chronic alcohol feeding (Figure 15G). 
DOI:10.14753/SE.2016.1906
 31 
A
0 .0
0 .5
1 .0
1 .5
2 .0
P ro - IL -1   m R N A  C e re b e llu m
5  w e e k s  fe e d in g
m
R
N
A
 (
fo
ld
 c
h
a
n
g
e
) * C tr
E tO H
             B
0
2
4
6
P ro - IL -1   m R N A  C e re b ru m
5  w e e k s  fe e d in g
m
R
N
A
 (
fo
ld
 c
h
a
n
g
e
) * C tr
E tO H
 
C
0
1
2
3
IL -1   P ro te in  C e re b e llu m
5  w e e k s  fe e d in g
IL
-1

  
(f
o
ld
 c
h
a
n
g
e
) * C tr
E tO H
             D
0 .0
0 .5
1 .0
1 .5
IL -1   P r o te in  C e r e b ru m
5  w e e k s  fe e d in g
IL
-1

  
(f
o
ld
 c
h
a
n
g
e
) * C tr
E tO H
 
E
C t r EtOH
M a tu r e  IL - 1 
 -a c t in
1 7  k D a
4 2  k D a
W e s t e r n  B lo t  C e r e b e l lu m
5  w e e k s  f e e d in g
  F
0 .0
0 .5
1 .0
1 .5
2 .0
M a tu re  IL -1   P ro te in  C e re b e llu m
5  w e e k s  fe e d in g
D
e
n
s
it
o
m
e
tr
y
 (
fo
ld
 c
h
a
n
g
e
)
*
C tr
E tO H
 
G
C e r e b r u m C e r e b e llu m
0 .0
0 .5
1 .0
1 .5
IL -1   P ro te in  B ra in
5  w e e k s  fe e d in g
IL
-1

  
(f
o
ld
 c
h
a
n
g
e
) * *
C tr
E tO H
 
Figure 15. Cerebellar IL-1β level in chronic alcohol-fed mice. Wild type mice were fed with 5% 
ethanol containing (EtOH; n=6) or isocaloric (Ctr; n=8) diet for 5 weeks. Pro-interleukin-1β (pro-IL-1β) 
mRNA was assessed by qRT-PCR in cerebellum (A) or cerebrum (B) using 18S internal control. IL-1β 
protein in whole cerebellar (C) or cerebral (D) lysates was assessed by specific ELISA (G). Mature IL-1β 
in whole cerebellar lysates was assessed by Western blot using β-actin loading control (E), and further 
quantified by densitometry (F). Bars represent mean±SEM (*: P value<0.05 relative to appropriate 
controls by Kruskal-Wallis non-parametric test). 
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6.2.4. Cerebellar inflammasome expression in chronic alcohol-fed mice 
Murine cerebellar NLRP1, NLRP3, ASC and pro-caspase-1 mRNAs are significantly 
higher after chronic alcohol-feeding compared to controls (Figure 16A). Similarly the 
levels of cerebral NLRP1, NLRP3, ASC and pro-caspase-1 mRNAs are significantly 
higher in chronic alcohol-fed compared to control mice (Figure 16B). 
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Figure 16. Cerebellar inflammasome expression in chronic alcohol-fed mice. Wild type mice were 
fed with 5% ethanol containing (EtOH; n=6) or isocaloric (Ctr; n=8) diet for 5 weeks. Inflammasome 
sensors (NLRP1 and NLRP3), inflammasome adaptor (ASC) and inflammasome effector (pro-caspase-1) 
mRNA was assessed by qRT-PCR in cerebellum (A) or cerebrum (B) using 18S internal control. Bars 
represent mean±SEM (*: P value<0.05 relative to appropriate controls by Kruskal-Wallis non-parametric 
test). 
 
6.2.5. Cerebellar inflammasome activation in chronic alcohol-fed mice 
Caspase-1 activity is significantly higher in murine cerebellum (Figure 17A) and 
cerebrum (Figure 17B) after chronic alcohol feeding compared to controls. Pro-caspase-
1 and caspase-1 p10 are significantly higher in murine cerebellum after chronic alcohol 
feeding compared to controls (Figure 17C-D). 
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Figure 17. Cerebellar inflammasome activation in chronic alcohol-fed mice. Wild type mice were fed 
with 5% ethanol containing (EtOH; n=6) or isocaloric (Ctr; n=8) diet for 5 weeks. Inflammasome activity 
was measured by caspase-1 colorimetric assay from whole cerebellar (A) or cerebral (B) lysates. Pro-
caspase-1 and caspase-1 p10 levels were visualized on Western blot using β-actin loading control (C), and 
further quantified by densitometry (D). Bars represent mean±SEM (*: P value<0.05 relative to 
appropriate controls by Kruskal-Wallis non-parametric test). 
 
6.2.6. Serum alcohol content in chronic alcohol-fed mice with different genotypes 
Mice receiving 5 weeks of alcohol feeding have significantly higher blood alcohol 
content than their appropriate controls regardless of their genotype (WT; TLR4-KO; 
NLRP3-KO; ASC-KO) (Figure 18). No statistically significant difference of blood 
alcohol content of mice is found among different genotypes (WT vs TLR4-KO; WT vs 
NLRP3-KO and ASC-KO) after 5 weeks of alcohol feeding (Figure 18). 
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Figure 18. Serum alcohol content in chronic alcohol-fed mice with different genotypes. Wild type 
(WT; n=7-14 or 6-8), TLR4-KO (n=13 or 8), NLRP3-KO (n=10 or 8) and ASC-KO (n=12 or 8) mice 
were fed with ethanol (EtOH) or isocaloric (Ctr) diet for 5 weeks, respectively. Blood alcohol content in 
serum was measured using alcohol analyzer. Bars represent mean±SEM (*: P value<0.05 relative to 
appropriate isocaloric controls by Kruskal-Wallis non-parametric test). 
DOI:10.14753/SE.2016.1906
 34 
 
6.2.7. Cerebellar IL-1β level in chronic alcohol-fed NLRP3-KO and ASC-KO mice 
Cerebellar IL-1β protein level is significantly higher after chronic alcohol feeding in 
wild type (WT) mice whereas no significant difference of cerebellar IL-1β protein level 
is found between alcohol-fed NLRP3-KO or ASC-KO and their appropriate control 
mice (Figure 19A-B). Cerebellar mature IL-1β protein level is significantly lower in 
chronic alcohol-fed NLRP3-KO compared to WT mice (Figure 19A-B). 
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Figure 19. Cerebellar IL-1β level in chronic alcohol-fed NLRP3-KO and ASC-KO mice. Wild type 
(WT; n=14 or 7), NLRP3-KO (n=10 or 8), and ASC-KO (n=12 or 9) mice were fed with 5% ethanol 
containing (EtOH) or isocaloric (Ctr) diet for 5 weeks, respectively. Mature IL-1β in whole cerebellar 
lysates was assessed by Western blot using β-actin loading control (A), and further quantified by 
densitometry (B). Bars represent mean±SEM (*: P value<0.05 relative to appropriate Ctr or WT-EtOH 
controls by Kruskal-Wallis non-parametric test). 
 
6.2.8. Cerebellar inflammasome activation in chronic alcohol-fed NLRP3-KO and ASC-
KO mice 
Caspase-1 activity is significantly higher in WT murine cerebellum after chronic 
alcohol feeding compared to controls (Figure 17B, 20). No difference of cerebellar 
caspase-1 activity is found between chronic alcohol-fed NLRP3-KO or ASC-KO and 
their appropriate control mice (Figure 20). 
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Figure 20. Cerebellar inflammasome activation in chronic alcohol-fed NLRP3-KO and ASC-KO 
mice. Wild type (WT; n=14 or 7), NLRP3-KO (n=10 or 8), and ASC-KO (n=12 or 9) mice were fed with 
5% ethanol containing (EtOH) or isocaloric (Ctr) diet for 5 weeks, respectively. Inflammasome activity 
was measured by caspase-1 colorimetric assay from whole cerebellar lysates. Bars represent mean±SEM 
(*: P value<0.05 relative to appropriate controls by Kruskal-Wallis non-parametric test). 
 
6.2.9. Cerebellar receptor expression in chronic alcohol-fed mice 
Murine cerebellar Toll-like receptors, TLR2, TLR4, TLR9 and receptor for advanced 
glycation end products (RAGE) mRNAs are significantly higher after chronic alcohol-
feeding compared to controls (Figure 21A). 
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Figure 21. Cerebellar receptor expression in chronic alcohol-fed mice. Wild type mice were fed with 
5% ethanol containing (EtOH; n=6) or isocaloric (Ctr; n=8) diet for 5 weeks. Toll-like receptors (TLR2, 
TLR4, TLR9) and receptor for advanced glycation end products (RAGE) mRNA was assessed by qRT-
PCR in cerebellum using 18S internal control. Bars represent mean±SEM (*: P value<0.05 relative to 
appropriate controls by Kruskal-Wallis non-parametric test). 
 
6.2.10. Cerebellar TNFα level in chronic alcohol-fed TLR4-KO mice 
Murine cerebellar TNFα protein levels are significantly higher after chronic alcohol 
feeding (Figure 14B, 22). No significant difference of cerebellar TNFα protein level is 
found between chronic alcohol-fed TLR4-KO and isocaloric control mice (Figure 22). 
Furthermore, cerebellar TNFα protein level is significantly lower in chronic alcohol-fed 
TLR4-KO compared to WT mice (Figure 22). 
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Figure 22. Cerebellar TNFα level in chronic alcohol-fed TLR4-KO mice. Wild type (WT; n=7 or 8) 
and Toll-like receptor-4 knockout (TLR4-KO; n=13 or 8) mice were fed with 5% ethanol containing 
(EtOH) or isocaloric (Ctr) diet for 5 weeks, respectively. TNFα protein in whole cerebellar lysates was 
assessed by specific ELISA. Bars represent mean±SEM (*: P value<0.05 relative to appropriate Ctr or 
WT-EtOH controls by Kruskal-Wallis non-parametric test). 
 
6.2.11. Cerebellar IL-1β level in chronic alcohol-fed TLR4-KO mice 
Pro-IL-1β mRNA level is significantly higher in the cerebella of chronic alcohol-fed 
compared to control mice (Figure 15A, 23A). Similarly murine cerebellar IL-1β protein 
levels are significantly higher after chronic alcohol feeding (Figure 15C, 23B). The 
levels of cerebellar pro-IL-1β mRNA (Figure 23A) and IL-1β protein (Figure 23B) are 
significantly higher in chronic alcohol-fed TLR4-KO compared to isocaloric control 
mice. The levels of cerebellar pro-IL-1β mRNA (Figure 23A) and IL-1β protein (Figure 
23B) are significantly lower in either isocaloric or chronic alcohol-fed TLR4-KO 
compared to WT mice. 
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Figure 23. Cerebellar IL-1β level in chronic alcohol-fed TLR4-KO mice. Wild type (WT; n=7 or 8) 
and Toll-like receptor-4 knockout (TLR4-KO; n=13 or 8) mice were fed with 5% ethanol containing 
(EtOH) or isocaloric (Ctr) diet for 5 weeks, respectively. Pro-interleukin-1β (pro-IL-1β) mRNA was 
assessed by qRT-PCR in cerebellum using 18S internal control (A). IL-1β protein in whole cerebellar 
lysates was assessed by specific ELISA (B). Bars represent mean±SEM (*: P value<0.05 relative to 
appropriate Ctr or WT-EtOH controls; #: P value<0.05 relative to appropriate WT-Ctr controls by 
Kruskal-Wallis non-parametric test). 
 
6.2.12. Cerebellar inflammasome expression in chronic alcohol-fed TLR4-KO mice 
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Murine cerebellar TLR4, NLRP1, NLRP3, ASC and pro-caspase-1 mRNAs are 
significantly higher in chronic alcohol-fed compared to control mice (Figure 16A, 21A, 
24A-E). 
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Figure 24. Cerebellar inflammasome expression in chronic alcohol-fed TLR4-KO mice. Wild type 
(WT; n=7 or 8) and Toll-like receptor-4 knockout (TLR4-KO; n=13 or 8) mice were fed with 5% ethanol 
containing (EtOH) or isocaloric (Ctr) diet for 5 weeks, respectively. TLR4 (A), inflammasome sensors 
NLRP1 (B) and NLRP3 (C), inflammasome adaptor ASC (D) and inflammasome effector pro-caspase-1 
(E) mRNA was assessed by qRT-PCR in cerebellum using 18S internal control. Bars represent 
mean±SEM (*: P value<0.05 relative to appropriate Ctr or WT-EtOH controls; #: P value<0.05 relative to 
appropriate WT-Ctr controls by Kruskal-Wallis non-parametric test). 
 
Cerebellar TLR4 is not detectable in TLR4-KO mice and therefore is significantly lower 
than WT controls receiving either chronic alcohol or isocaloric diet (Figure 24A). The 
level of cerebellar NLRP1 (Figure 24B), NLRP3 (Figure 24C), ASC (Figure 24D) and 
pro-caspase-1 (Figure 24E) mRNA is significantly higher in chronic alcohol-fed WT or 
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TLR4-KO compared to isocaloric control mice. The level of cerebellar NLRP1 (Figure 
24B), NLRP3 (Figure 24C), ASC (Figure 24D) and pro-caspase-1 (Figure 24E) mRNA 
is significantly lower in either isocaloric or chronic alcohol-fed TLR4-KO compared to 
WT mice. 
 
6.2.13. Cerebellar inflammasome activation in chronic alcohol-fed TLR4-KO mice 
Caspase-1 activity is significantly higher in WT murine cerebellum after chronic 
alcohol feeding compared to controls (Figure 17B, 20, 25). Similarly caspase-1 activity 
is significantly higher in TLR4-KO murine cerebellum after chronic alcohol feeding 
compared to controls (Figure 25). No significant difference of cerebellar caspase-1 
activity is found between chronic alcohol-fed WT and TLR4-KO mice (Figure 25). 
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Figure 25. Cerebellar inflammasome activation in chronic alcohol-fed TLR4-KO mice. Wild type 
(WT; n=7 or 8) and Toll-like receptor-4 knockout (TLR4-KO; n=13 or 8) mice were fed with 5% ethanol 
containing (EtOH) or isocaloric (Ctr) diet for 5 weeks, respectively. Inflammasome activity was measured 
by caspase-1 colorimetric assay from whole cerebellar lysates. Bars represent mean±SEM (*: P 
value<0.05 relative to appropriate controls by Kruskal-Wallis non-parametric test). 
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Figure 26. Endotoxin level in the cerebellum of chronic alcohol-fed mice. Wild type mice were fed 
with 5% ethanol containing (EtOH; n=8) or isocaloric (Ctr; n=7) diet for 5 weeks. Endotoxin 
measurement was executed in serum and whole cerebellar lysates using Limulus Amebocyte Lysate-
assay. Bars represent mean±SEM (*: P value<0.05 relative to appropriate controls by Kruskal-Wallis 
non-parametric test). 
 
DOI:10.14753/SE.2016.1906
 39 
6.2.14. Endotoxin level in the cerebellum of chronic alcohol-fed mice 
Despite the higher serum-endotoxin levels in alcohol-fed mice (Figure 7B, 26), no 
difference of cerebellar endotoxin level is found between chronic alcohol-fed and 
control mice (Figure 26). 
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Figure 27. Cerebellar HMGB1 level and activation of chronic alcohol-fed mice. Wild type mice were 
fed with 5% ethanol containing (EtOH; n=6) or isocaloric (Ctr; n=8) diet for 5 weeks. HMGB1 mRNA 
was assessed by qRT-PCR in cerebellum using 18S internal control (A).  Total HMGB1 of whole 
cerebellar lysates was analyzed by Western blot using β-actin loading control (B) and quantified further 
by densitometry (C). Acetyl- (Ac-) and phospho- (P-) HMGB1 of whole cerebellar lysates were analyzed 
by IP using β-actin Western blot for loading control on a separate gel (D) and assessed further by 
densitometry (E). Cerebellar lysate of one representative alcohol-fed mouse was applied for IgG control 
(IgG ctr), using the same amount of protein. Bars represent mean±SEM (*: P value<0.05; NS: not 
significant; relative to appropriate controls by Kruskal-Wallis non-parametric test). 
 
6.2.15. Cerebellar HMGB1 level and activation of chronic alcohol-fed mice 
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Cerebellar HMGB1 mRNA is significantly higher in chronic alcohol-fed compared to 
control mice (Figure 27A). No significant difference of cerebellar total HMGB1 protein 
is found between chronic alcohol-fed and control mice (Figure 27B-C). Using 
immunoprecipitation, both acetylated- and phosphorylated-HMGB1 levels are 
significantly higher in the cerebellum of chronic alcohol-fed compared to control mice 
(Figure 27D-E). 
 
6.2.16. Interleukin-1 receptor and interleukin-1 receptor antagonist in the cerebellum of 
chronic alcohol-fed mice 
No difference of cerebellar interleukin-1 receptor (IL-1R) is found between chronic 
alcohol-fed and control mice (Figure 28) [unpublished data]. Mice receiving 5 weeks of 
alcohol feeding have significantly higher endogenous IL-1R antagonist levels in the 
cerebellum compared to controls (Figure 28). 
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Figure 28. Interleukin-1 receptor and interleukin-1 receptor antagonist in the cerebellum of 
chronic alcohol-fed mice [partially unpublished data]. Wild type mice were fed with 5% ethanol 
containing (EtOH; n=6) or isocaloric (Ctr; n=8) diet for 5 weeks. Interleukin-1 receptor (IL-1R) and IL-
1R antagonist (IL-1Ra) mRNA was assessed by qRT-PCR in cerebellum using 18S internal control. Bars 
represent mean±SEM (*: P value<0.05 relative to appropriate controls by Kruskal-Wallis non-parametric 
test). 
 
6.2.17. Cerebellar TNFα level in chronic alcohol-fed recombinant interleukin-1 
receptor antagonist treated mice 
Both cerebellar TNFα mRNA (Figure 14A, 29A) and protein (Figure 14B, 22, 29B) 
levels are significantly higher in chronic alcohol-fed compared to control mice. No 
significant difference of cerebellar TNFα mRNA is found between chronic alcohol-fed 
and isocaloric control mice after recombinant interleukin-1 receptor antagonist (rIL-
1Ra) treatment (Figure 29A). In contrast cerebellar TNFα protein is significantly higher 
in chronic alcohol-fed rIL-1Ra compared to appropriate isocaloric control mice (Figure 
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29B). Both cerebellar TNFα mRNA (Figure 29A) and protein (Figure 29B) levels are 
significantly lower in rIL-1Ra compared to saline treated mice after chronic alcohol 
feeding. 
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Figure 29. Cerebellar TNFα level in chronic alcohol-fed recombinant interleukin-1 receptor 
antagonist treated mice. Wild type mice were fed with 5% ethanol containing (EtOH; n=9 or 7) or 
isocaloric (Ctr; n=5 or 8) diet and received daily intra peritoneal recombinant interleukin-1 receptor 
antagonist (rIL-1Ra; anakinra: 25 mg/kg) or an equal amount of saline injections for 5 weeks, 
respectively. Tumor necrosis factor-α (TNFα) mRNA was assessed by qRT-PCR in cerebellum using 18S 
internal control (A). TNFα protein in whole cerebellar lysates was assessed by specific ELISA (B). Bars 
represent mean±SEM (*: P value<0.05 relative to appropriate Ctr or saline-EtOH controls by Kruskal-
Wallis non-parametric test). 
 
6.2.18. Cerebellar IL-1β level in chronic alcohol-fed recombinant interleukin-1 
receptor antagonist treated mice 
Both cerebellar pro-IL-1β mRNA (Figure 15A, 23A, 30A) and IL-1β protein (Figure 
15C, 23B, 30B) levels are significantly higher after chronic alcohol feeding compared to 
control mice. 
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Figure 30. Cerebellar IL-1β level in chronic alcohol-fed recombinant interleukin-1 receptor 
antagonist treated mice. Wild type mice were fed with 5% ethanol containing (EtOH; n=9 or 7) or 
isocaloric (Ctr; n=5 or 8) diet and received daily intra peritoneal recombinant interleukin-1 receptor 
antagonist (rIL-1Ra; anakinra: 25 mg/kg) or an equal amount of saline injections for 5 weeks, 
respectively. Pro-interleukin-1β (pro-IL-1β) mRNA was assessed by qRT-PCR in cerebellum using 18S 
internal control (A). IL-1β protein in whole cerebellar lysates was assessed by specific ELISA (B). Bars 
represent mean±SEM (*: P value<0.05 relative to appropriate Ctr controls; #: P value<0.05 relative to 
appropriate saline-Ctr controls by Kruskal-Wallis non-parametric test). 
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No significant difference of either cerebellar pro-IL-1β mRNA (Figure 30A) or IL-1β 
protein (Figure 30B) is found between chronic alcohol-fed recombinant interleukin-1 
receptor antagonist (rIL-1Ra) and appropriate isocaloric control mice. The background 
of cerebellar IL-1β protein level is significantly higher in rIL-1Ra compared to saline 
treated mice receiving isocaloric diet (Figure 30B). 
 
6.2.19. Cerebellar receptor and inflammasome expression in chronic alcohol-fed 
recombinant interleukin-1 receptor antagonist treated mice 
No significant difference of cerebellar receptor (TLR2, TLR4, TLR9), inflammasome 
(NLRP1, NLRP3, ASC, pro-caspase-1), IL-1R or endogenous IL-1Ra mRNA is found 
between chronic alcohol-fed rIL-1Ra and isocaloric control mice (Figure 31) 
[unpublished data]. 
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Figure 31. Cerebellar receptor and inflammasome expression in chronic alcohol-fed recombinant 
interleukin-1 receptor antagonist treated mice [unpublished data]. Wild type mice were fed with 5% 
ethanol containing (EtOH; n=9 or 7) or isocaloric (Ctr; n=5 or 8) diet and received daily intra peritoneal 
recombinant interleukin-1 receptor antagonist (rIL-1Ra; anakinra: 25 mg/kg) or an equal amount of saline 
injections for 5 weeks, respectively. Toll-like receptors (TLR2, TLR4, TLR9), inflammasome sensors 
(NLRP1 and NLRP3), inflammasome adaptor (ASC), inflammasome effector (pro-caspase-1), 
interleukin-1 receptor (IL-1R) and IL-1R antagonist (IL-1Ra) mRNA was assessed by qRT-PCR in 
cerebellum using 18S internal control. Bars represent mean±SEM (NS: not significant relative to 
appropriate controls by Kruskal-Wallis non-parametric test). 
 
6.2.20. Cerebellar inflammasome activation in chronic alcohol-fed recombinant 
interleukin-1 receptor antagonist treated mice 
Caspase-1 activity is significantly higher in WT murine cerebellum after chronic 
alcohol feeding compared to controls (Figure 17B, 20, 25, 32). Similarly caspase-1 
activity is significantly higher in chronic alcohol-fed rIL-1Ra treated compared to 
appropriate isocaloric control mice (Figure 32). Cerebellar caspase-1 activity is 
significantly lower in rIL-1Ra treated compared to saline treated mice after chronic 
alcohol feeding (Figure 32). 
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Figure 32. Cerebellar inflammasome activation in chronic alcohol-fed recombinant interleukin-1 
receptor antagonist treated mice. Wild type mice were fed with 5% ethanol containing (EtOH; n=9 or 
7) or isocaloric (Ctr; n=5 or 8) diet and received daily intra peritoneal recombinant interleukin-1 receptor 
antagonist (rIL-1Ra; anakinra: 25 mg/kg) or an equal amount of saline injections for 5 weeks, 
respectively. Inflammasome activity was measured by caspase-1 colorimetric assay from whole cerebellar 
lysates. Bars represent mean±SEM (*: P value<0.05 relative to appropriate Ctr or saline-EtOH controls 
by Kruskal-Wallis non-parametric test). 
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Figure 33. Cerebellar HMGB1 activation in chronic alcohol-fed recombinant interleukin-1 receptor 
antagonist treated mice. Wild type mice were fed with 5% ethanol containing (EtOH; n=9 or 7) or 
isocaloric (Ctr; n=5 or 8) diet and received daily intra peritoneal recombinant interleukin-1 receptor 
antagonist (rIL-1Ra; anakinra: 25 mg/kg) or an equal amount of saline injections for 5 weeks, 
respectively. Acetyl- (Ac-) HMGB1 of whole cerebellar lysates were analyzed by IP using β-actin 
Western blot for loading control on a separate gel (A) and assessed further by densitometry (B). 
Cerebellar lysate of one representative alcohol-fed mouse was applied for IgG control (IgG ctr), using the 
same amount of protein. Bars represent mean±SEM (*: P value<0.05 relative to appropriate controls by 
Kruskal-Wallis non-parametric test). 
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6.2.21. Cerebellar HMGB1 activation in chronic alcohol-fed recombinant interleukin-1 
receptor antagonist treated mice 
Using immunoprecipitation, acetylated-HMGB1 level is significantly higher in the 
cerebellum of chronic alcohol-fed compared to control mice (Figure 27D-E, 33A-B). 
However no significant difference of cerebellar acetylated-HMGB1 is found between 
chronic alcohol-fed rIL-1Ra treated and appropriate isocaloric control mice (Figure 
33A-B). 
 
6.2.22. Cerebellar TNFα and pro-IL-1β levels in response to intracranial recombinant 
IL-1β injection in mice 
Cerebellar TNFα and pro-IL-1β mRNA (Figure 34A) as well as TNFα protein (Figure 
34B) are significantly higher in mice receiving intracranial recombinant IL-1β injection 
compared to saline treated controls. 
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Figure 34. Cerebellar TNFα and pro-IL-1β levels in response to intracranial recombinant IL-1β 
injection in mice. Wild type mice received 100 ng (30 μl) intracranial mouse recombinant interleukin-1β 
(rIL-1β) (n=7) or an equal amount of saline solution (n=8). Tumor necrosis factor-α (TNFα) and pro-IL-
1β mRNA was assessed by qRT-PCR in cerebellum using 18S internal control (A). TNFα protein in 
whole cerebellar lysates was assessed by specific ELISA (B). Bars represent mean±SEM (*: P value<0.05 
relative to appropriate controls by Kruskal-Wallis non-parametric test). 
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7. DISCUSSION 
 
7.1. General considerations 
These studies were executed in animal models, main conclusions should be cautiously 
drawn on generalizability in human. Human studies are necessary to confirm our 
findings. As a general role process of preparing knock-out animals might affect the 
outcome as theoretically removal of a gene can alter other mechanisms. Therefore other 
forms of pharmaceutical silencing should confirm our findings. The homogeneity of our 
animals (including age, gender, etc.) and the laboratory conditions (including air-, light 
conditions, diet, etc.) removed all known confounding variations. As cases and controls 
were treated equally, any possible factor should affect both groups in a similar direction. 
In this study our target was to evaluate the intestinal mucosa, therefore we discarded 
immune cell clusters within the Peyer patches which are involved in the pathogenesis of 
inflammation. Though it is a standard type of method for mucosal research. Using 
particular parts of the body like the cerebellum and proximal small intestine allows us to 
narrow down our conclusion toward specific sites. 
 
7.2. Proximal small intestine 
Mice receiving either one-time alcohol gavage or 5 weeks of alcohol feeding have 
significantly higher blood alcohol content than their appropriate controls. 
Alcohol use, both acute binge and chronic alcohol intake, has numerous negative health 
effects on different organs including the intestine [14, 97]. The first line of attack of 
alcohol in the body is its entrance route, mainly the gastrointestinal system [14]. As a 
result the integrity of the mucosal barrier is lost and bacterial cell wall particles seep 
through into the circulation leading to elevated endotoxin levels in the sera of alcoholic 
patients [52]. Our observation confirmed previous reports of increased endotoxin levels 
in chronic alcohol feeding [98] and demonstrated that increase in serum endotoxin after 
acute alcohol binge was transient. 
In this study we focused on the proximal small intestine which is in the first line of 
contact with alcohol and has a different pattern of gene activation than other parts. 
Antibacterial proteins are important elements of the mucosal innate immune system and 
are reportedly decreased in chronic alcoholics [19]. Similarly, in our model chronic 
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alcohol feeding reduces the antibacterial protein, Reg3b, level in the proximal small 
intestine. Interestingly, acute alcohol binge increases Reg3b level while increased serum 
endotoxin is still implying the loss of barrier function. We speculate that increased 
Reg3b may represent a compensatory mechanism to repair or maintain gut barrier after 
an acute alcohol binge. While this mechanism is likely to be exhausted after repeated 
and sustained alcohol exposure in a chronic model, resulting in decreased Reg3b levels 
affirmed by others’ and our findings. These observations suggest that both acute binge 
and chronic alcohol intake disturbs the gut mucosal barrier function. 
It is notable that the control group of the chronic feeding has higher amount of intestinal 
Reg3b protein (longer exposure) than acute gavage controls. The increased baseline 
Reg3b production in chronic feeding might be attributable to the high fat content of the 
applied diet, as in high-fat diet model the transcription of Reg3b of the neighbor 
mesenteric adipose tissue is induced [99]. However we cannot rule out the possibility of 
post-transcriptional or post-translational modifications of Reg3b in our models. 
Once there is a mucosal barrier breach inflammatory changes start developing at the 
site. Based on previous studies NF-κB activation and pro-inflammatory cytokine, TNFα 
release play an important role in regulating intestinal epithelial function in inflammatory 
bowel disease [26, 27]. TNFα secreting cells are increased in the inflamed mucosa in 
IBD [100]. Upregulation of TNFα involves activation of transcription factors, such as 
NF-κB [101] or activator protein-1 (AP-1) [102]. NF-κB is a major regulator in 
proinflammatory pathways and can upregulate multiple proinflammatory cytokines and 
chemokines, including TNFα and pro-IL-1β [85, 87]. We established that TNFα protein 
increased only in chronic alcohol feeding in the proximal small intestine. Both acute 
and chronic alcohol consumption increase TNFα mRNA and yet acute binge only 
minimally increases NF-κB. NF-κB is not the sole mediator of TNFα induction, 
therefore in our acute binge model there might be other transcription factors involved in 
the upregulation of TNFα mRNA, such as AP-1 [102].  
Despite the fact that acute alcohol increases TNFα mRNA, TNFα protein levels 
remained unchanged while in chronic alcohol feeding TNFα protein levels were 
elevated. This phenomenon could be in part due to post-transcriptional modification by 
miR-155, which is induced in chronic alcohol feeding in contrast to the lack of 
induction of miR-155 in the acute binge drinking model. MiRNA-155 is a positive 
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regulator of TNFα by increasing its mRNA stability in macrophages [103]. Further 
work on other possible post-transcriptional or post-translational modifications are 
necessary. 
The data suggest that chronic alcohol leads to a robust inflammatory response in 
proximal small intestine characterized by increased TNFα, NF-κB activation and 
reduced expression of the antimicrobial protein, Reg3b. Our results indicate that in 
contrast to chronic alcohol feeding, acute alcohol binge results in a transient increase in 
serum endotoxin and a further increase in Reg3b leading to the speculation that rapid 
restoration of the gut barrier may occur after barrier disruption caused by acute alcohol 
binge, whereas chronic alcohol-fed mice might lose this reserve capacity during time. 
NF-κB pathway also mediates IL-1β increase and augmented IL-1β is associated with 
enhanced permeability in Caco2 cell line [30]. Furthermore, IL-1β gene polymorphisms 
are associated with the course and severity of IBD [104]. Colitis driven by specific 
microbiota is associated with induced monocytic IL-1β release [105]. Recent data 
involving small number of patients is inconclusive on whether IL-1β signaling blockage 
by IL-1Ra treatment is beneficial or not in IBD [106, 107]. Based on alcohol induced 
intestinal NF-κB activity and increased endotoxin level, we evaluated IL-1β production 
in the chronic alcohol-fed mouse model where the inflammatory changes seemed to be 
more robust than in the acute binge model. Even though intestinal NF-κB activity is 
increased in both alcohol gavage and chronic alcohol feeding model there is no 
difference of pro-IL-1β mRNA or IL-1β protein between either alcohol gavage or 
chronic alcohol-feeding and appropriate controls. Similarly there is no difference of 
mRNA expression of inflammasome components between either alcohol gavage or 
chronic alcohol-feeding and appropriate controls. These data suggest no inflammasome 
involvement in the proximal intestine of alcohol-fed mice. Interestingly, a recent report 
shows increased murine proximal intestinal IL-1β mRNA level one hour after 
intraperitoneal administration of 20% 5.5 or 8.25g/kg ethanol [108]. The differences 
between the methodologies certainly could account for the discrepancies in the findings, 
as our three times 50% 5g/kg oral alcohol administration was checked at 6h after the 
last gavage. Additionally in our study the Peyer patches, a collection of immune cells, 
were discarded, which might be responsible for inflammasome activation. More detailed 
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studies are warranted to understand the relation between inflammatory response of 
proximal intestine and the harmful effects of alcohol. 
 
7.3. Liver 
Alcohol, DAMPs and PAMPs originating from the intestine can affect other organs, 
including the site of first pass metabolism, the liver. Amplification of TNFα production 
by chronic alcohol in Kupffer cells involves alcohol-induced induction of NF-κB 
activation [103]. Our results showed that TLR4 signaling and activation of 
inflammasome complex followed by IL-1β production are involved in the pathogenesis 
of alcoholic liver disease [34, 62]. Furthermore, caspase-1, ASC and IL-1R deficiency 
protected chronic alcohol-fed mice against from developing alcoholic hepatitis and 
decreased the level of steatosis and liver damage [34].  
However, it has been showed that NLRP3 deficient alcohol-fed B6 mice were protected 
against alcohol-induced liver injury [109]. The possible explanations for the differences 
might be due to discrepancies in methodology, the increased levels of IL-18 and the 
possibility of increased leakage of LPS from altered microbiota [109, 110]. Similarly, 
ASC deficient mice are prone to develop liver injury in a non-alcoholic fatty liver 
disease / steatohepatitis model [110]. Further detailed studies are warranted to 
understand the role of ASC/NLRP3 on microbiota and inflammation in the context of 
alcohol. 
Results from our lab showed that IL-1R blockage with rIL-1Ra treatment prevents the 
development and progression of alcoholic liver disease [34]. Currently there is an 
ongoing clinical trial evaluating the efficacy of rIL-1Ra in severe acute alcoholic 
hepatitis [111]. 
 
7.4. Cerebellum 
Alcohol, PAMPs and DAMPs originating from intestine and liver via circulation and/or 
neural feedback mechanisms can affect the brain. 
Chronic ethanol feeding results in neuroinflammatory changes in cortical, hippocampal 
and cerebellar brain regions [45, 46]. Our study focused mainly on changes in the 
cerebellum after chronic alcohol intake. The immunological aspect of ethanol induced 
cerebellar damage has not yet been extensively studied and the high cellular density and 
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easy accessibility of cerebellum provides a preferable candidate for research. Alcohol 
intake impairs integration of sensory perception, coordination and motor control, which 
are functions of the cerebellum [112, 113]. In long term, alcohol consumption can lead 
to cerebellar atrophy which is in part due to malnutrition. Increasing evidences suggest 
that long-term neurodegenerative changes in the cerebellum of alcoholics are not solely 
due to lack of dietary factors and that immunological pathways might be involved [50]. 
The neuroinflammatory changes include induction of pro-inflammatory cytokines and 
chemokines, DAMPs, NF-κB, inflammasome and iNOS activation, NADPH-oxidase 
and ROS mediated pathways [45, 46]. To evaluate the mechanism by which cerebellum 
can be affected in our model of chronic alcohol feeding, we first evaluated NF-κB 
activation. Consistent with previous studies, there is an increase in NF-κB DNA binding 
in the cerebellum of chronic alcohol-fed WT mice compared to controls. 
While IL-1β protein production is largely dependent on caspase-1 activation, pro-IL-1β 
mRNA induction is NF-κB mediated [114]. We aimed to evaluate whether activated 
NF-κB can upregulate TNFα and pro-IL-1β in our animal model as a part of the 
inflammatory changes. Similar to the effects of long-term ethanol feeding in a rat 
model, our results indicate that chronic alcohol-fed mice have increased cerebellar 
protein levels of inflammatory mediators including TNFα and IL-1β [46]. Short-term 
ethanol administration in mice also results in increased brain TNFα levels, while IL-1β 
is only increased after additional intra-peritoneal LPS injection [43]. We observed that 
IL-1β induction by alcohol was identical in the cerebral cortex and the cerebellum of 
alcohol-fed mice suggesting that investigation of the cerebellum is one of the 
representative sites of alcohol-induced neuroinflammation. 
The rise in cerebellar IL-1β and TNFα could have serum origin, as chronic alcohol 
feeding increases serum cytokine levels and there are saturable transporter systems at 
the BBB [34, 115]. However in our study we observed an increase in NF-κB and 
inflammasome activation which is suggestive of a local cytokine production by 
cerebellar cells. 
Our data revealed IL-1β increment in the brain after chronic alcohol administration, 
therefore we evaluated the role of inflammasome activation as a contributor to IL-1β 
production. We showed that the mRNA expression of several inflammasome 
components including receptors, (NLRP1, NLRP3), adaptor (ASC) and effector (pro-
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caspase-1) are significantly increased in the cerebellum and cerebrum after chronic 
alcohol administration in mice. Caspase-1 is the effector enzyme of the inflammasome 
complex and it exerts its proteolytic effect on pro-IL-1β when the 45-kDa pro-caspase-1 
protein is cleaved into its active forms, caspase-1 p20- and p10-kDa subunits [81]. In 
our model caspase-1 activity is increased in the cerebella and cerebra of chronic 
alcohol-fed compared to pair-fed mice and increased levels of the active, cleaved 
caspase-1 p10 on Western blots support this finding (Figure 17). 
Several studies have shown the importance of the inflammasome in neuroinflammation. 
NLRP3 activation is involved in inflammation and tissue damage in response to 
amyloid-β in Alzheimer’s [93]. Attenuation of ASC or the NLRP1 receptor improves 
traumatic brain injury [96, 116]. Caspase-1 is involved in the pathogenesis of both 
neurodegenerative and neuroinfectious diseases [94, 95, 117]. Molecules such as 
NLRC4 [81, 118], absent in melanoma 2 (AIM2) receptors [119] and the pannexin-1 
channel [120] facilitate intracellular DAMP transport, stimulate the NLRP3 
inflammasome, and can be activated in the neural system [81, 118]. 
To further investigate the mechanistic role of inflammasome activation in alcohol-
induced IL-1β formation we evaluated neuroinflammation in mice deficient in the 
inflammasome sensor, NLRP3, or the adaptor molecule, ASC. In our animal model, 
NLRP3 and ASC are both necessary for inflammasome activation and IL-1β production 
as both NLRP3-KO and ASC-KO mice were protected from caspase-1 activation and 
increased IL-1β production. This was in contrast with the significant increase in 
cerebellar caspase-1 activity and mature IL-1β level in alcohol-fed WT mice. Our data 
suggest that the NLRP3 inflammasome complex is active and necessary in the cerebella 
of mice with chronic ethanol-feeding. This effect should not be the result of less alcohol 
intake in KO mice as animals were fed equally and serum alcohol levels were 
comparable between the genotypes. 
As two separate signals are required for NLRP3 inflammasome activation:  priming via 
TLRs to upregulate the expression of inflammasome components and a second signal to 
activate the inflammasome complex to cleave caspase-1 [82], we first evaluated the 
expression of some candidate receptors. Chronic alcohol feeding increases cerebellar 
mRNA of TLR2, TLR4, TLR9 and RAGE, as expected. NLRP3 inflammasome can be 
induced by either MyD88 or TRIF signaling pathways that are downstream of TLRs 
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[82]. Previous studies indicate that TLR4 ligands promote TNFα and MCP-1 production 
which contribute to microglia accumulation, astrogliosis and inflammatory cytokine 
production in alcoholic neuroinflammation [42, 46]. We investigated the role of TLR4 
in inflammasome activation in the brain. In contrast to WT mice, alcohol-fed TLR4-KO 
mice have no increase in TNFα protein levels in the cerebellum compared to controls. 
Previous studies showed that the cerebral cortex of TLR4-KO rats is protected from 
alcohol-induced IL-1β induction [46], a central mediator of neuroinflammation [121]. In 
our model there is an overall significantly attenuated expression of the inflammasome 
components (NLRP1, NLRP3, ASC) and effector molecule (pro-caspase-1) and 
decrease in pro-IL-1β mRNA and IL-1β protein levels in alcohol-fed TLR4-KO 
compared to WT mice, however the levels remain induced upon alcohol challenge. 
Alcohol-induced caspase-1 activity is comparable between TLR4-KO and WT mice. 
These data suggest that TLR4 only partially contributes to the expression, likely to the 
priming of inflammasome induction in the brain after alcohol feeding and that 
activation of the inflammasome is independent of TLR4. 
PAMPs, including LPS, activate the TLR4 signaling pathway [122]. LPS mediates 
alcoholic liver disease and is increased in the serum of chronic alcohol-fed mice [62] as 
well as in patients with alcoholic cirrhosis [63]. LPS could increase IL-1β directly via 
the TLR4-mediated pathway in the brain. Therefore we investigated the possible direct 
role of LPS in alcohol-induced inflammasome activation in the brain. Despite increased 
endotoxin levels in the serum, we found no detectable LPS in the brain of alcohol-fed 
mice. These data suggest that TLR4-mediated pathways are responsible for alcohol-
induced TNFα increment in the cerebellum even in the absence of LPS in the brain. 
Moreover, increased IL-1β in the cerebellum after alcohol-feeding was not fully TLR4- 
or directly LPS-mediated. Previous studies are controversial on the effect of alcohol on 
the integrity of the blood-brain-barrier. Some have found no increase in permeability 
[123-125], while others suggest impairment [126, 127]. Reports also indicate an indirect 
role for LPS in neuroinflammation [49]. Neuroimmune reflexes have been shown to 
sense and respond to peripheral injuries [49]. Vagotomy in animals intraperitoneally 
injected with LPS diminishes the IL-1β response in the brain, but not on the periphery 
or the pituitary gland [59]. While we cannot rule out indirect effects of LPS via extra-
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cerebral targets, our data suggest that LPS is not directly involved in neuroinflammation 
induced by alcohol. 
These observations led us to explore other danger molecules that could induce 
inflammation in our model. HMGB1, a DAMP, was shown to mediate ischemic brain 
damage [128] and nasal introduction of small interfering-RNA targeting HMGB1 in a 
post-ischemic brain injury model resulted in significant neuroprotection [129]. 
Interestingly, HMGB1 antibodies or small interfering RNA targeting HMGB1 were 
used effectively in arthritis, sepsis, cancer or post-ischemic brain injury models, all of 
which are associated with induction of the inflamamsome-IL-1β cascade [130]. 
Furthermore, recent reports suggest that HMGB1 can contribute to the activation of the 
inflammasome complex to cleave pro-IL-1β into its mature (17kD), biologically active 
form [90, 131]. NLRP3 and ASC, independent of caspase-1, are necessary for HMGB1 
release [130] and IL-1β can induce HMGB1-release from monocytes and macrophages 
[132, 133]. Posttranslational modification by acetylation and phosphorylation is 
important for translocation of nuclear HMGB1 to the cytoplasm and its subsequent 
release [134] as a result acetylated or phosphorylated HMGB1 is recognized as a danger 
signal [135, 136]. Although HMGB1 itself does not exert proinflammatory effects, upon 
phosphorylation, HMGB1 can enhance inflammation by binding to other cytokines and 
initiating or promoting signaling through TLR2, TLR4, TLR9, RAGE or IL-1R [89, 
135-137]. Similar to alcoholic steatohepatitis [138], HMGB1 receptor mRNA 
expression (TLR2, TLR4, TLR9 and RAGE) as well as phosphorylated and acetylated 
HMGB1 levels are induced by alcohol in murine cerebellum. These data suggest that 
HMGB1 is a possible DAMP that could induce signaling through TLRs to augment the 
inflammasome response and IL-1β production in alcoholic neuroinflammation. HMGB1 
also exerts neuronal apoptosis via caspase-3 and induces iNOS, TNFα, COX2 and IFNγ 
expression in primary microglia [139]. Increase in caspase-3 activity, iNOS, COX2 and 
IFNγ are observed in alcohol feeding [46]. Thus, it is feasible that in addition to 
activation of the inflammasome-caspase-1 complex, increased phosphorylated- and 
acetylated-HMGB1 could also contribute to caspase-3 activation in the brain of chronic 
alcoholic mice. 
IL-1β exerts its biologic function via the IL-1 receptor (IL-1R) and amplifies 
inflammation [83]. Although IL-1R mRNA remains unchanged after chronic alcohol 
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feeding, its activator IL-1β and natural endogenous inhibitor IL-1Ra are both increased. 
The inhibitor of IL-1R, IL-1Ra occupies the IL-1R without transducing activation 
unlike the activators, IL-1α and IL-1β [84]. The cerebellar alcohol-induced increase of 
IL-1Ra suggests the possible activation of a negative feedback loop in order to establish 
a new steady state. 
Recombinant IL-1Ra, anakinra, is a disease-modifying anti-inflammatory medication 
for active rheumatoid arthritis and has been suggested for treating a variety of diseases 
with excessive IL-1β production, including recurring-fever syndromes, gout or diabetes 
mellitus [140]. To evaluate the involvement of IL-1/IL-1R signaling in alcohol-induced 
neuroinflammation, we treated mice with daily doses of 25mg/kg recombinant IL-1Ra, 
anakinra, during alcohol feeding [34]. In short-term ethanol administration in mice, IL-
1Ra pretreatment efficiently reduced the sedation and motor impairment recovery time 
[141] supporting the observation that IL-1 signaling is involved in alcohol-induced 
neuroinflammatory changes. Moreover our in vivo experiments suggest that rIL-1Ra 
interrupts the circuit of neuroinflammation and prevents the excessive activation of the 
inflammasome complex and neuroinflammation in the cerebellum of chronic alcohol-
fed mice. Recombinant IL-1Ra treatment prevented the alcohol-induced mRNA 
expression of receptors (TLR2, TLR4, TLR9), inflammasome components (NLRP1, 
NLRP3, ASC, procaspase-1), proinflammatory cytokines (TNF-α, pro-IL-1β) and IL-
1Ra in the cerebellum. Furthermore, rIL-1ra administration significantly attenuated 
TNF-α protein levels in alcohol-fed mice, suggesting interruption of the positive-
feedback loop in inflammatory cytokine production. Importantly, there was no increase 
in IL-1β protein levels, and caspase-1 activity was significantly attenuated in rIL-1ra 
treated alcohol-fed mice. There is increasing evidence for a feed-forward activation 
between acetylated HMGB1 and IL-1 as IL-1β can induce HMGB1 acetylation and 
therefore contributes to its release in monocytes [133]. Consistent with this notion, rIL-
1Ra treatment prevented the increase in acetylated HMGB1 in alcohol-fed mice in our 
model. 
To evaluate whether a positive pro-inflammatory feedback loop was induced by IL-1β 
in the cerebellum, some mice received intracranial injection of recombinant mouse IL-
1β, which resulted in increased TNFα and IL-1β mRNA as well as TNFα protein levels 
in the cerebellum. Altogether these data suggest an interruption of the positive feedback 
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loop in inflammatory cytokine/DAMP production by rIL-1Ra. All of these findings 
might be also beneficial for the patients in the ongoing trial evaluating the efficacy of 
rIL-1Ra in severe acute alcoholic hepatitis [111]. 
 
7.5. Concluding remarks and human relevance 
Structure (histology) of human and murine organs (small intestine, liver or cerebellum) 
are similar [142]. There are evolutionary preserved biological responses to harmful 
agents, as alcohol induced immune response identified in murine or human intestine, 
liver and brain are similar corroborated by research on cadavers, biopsy samples and 
cell lines [23, 24, 43-47, 143]. Alcohol induced gut permeability is increased, 
neuroinflammation is present in both species and increasing evidence suggest that these 
pathways are leastwise overlapping [23, 24, 43-47, 143]. Alcohol impairs hippocampal 
neurogenesis and cerebral innate immune response has been linked to the addictive 
effect of alcohol [47, 144, 145]. The presented data raise new questions, including 
where exactly the organ damage cascade begin; what the first organ is to be affected by 
alcohol in inducing inflammation; can this inflammatory cascade be stopped and where; 
is there an organ-organ crosstalk which is suggested by the findings of the intracerebral 
injection of IL-1β; these questions warrant further research. All of the research effort is 
in order to find feasible intervention for the inflammatory pathways of alcohol-induced 
end organ damage.  
 
7.6. Future perspectives 
 The change from augmented to suppressed antimicrobial protein levels in the 
proximal intestine in acute vs chronic models is not fully understood. Further 
mechanical studies are warranted. 
 Due to alcohol-induced colonic mucosal and microbiota changes large intestinal 
inflammasome activation might be informative. In addition to IL-1β, studying 
other members of the same signaling pathway might shed light to the underlying 
mechanism. 
 The association between gender and the inflammasome activation is not known, 
and there is no evidence of difference. However, it might be of value to do 
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studies using both male and female mice to recognize possible gender 
differences. 
 Both astrocytes and microglia has been shown to be involved in the 
inflammasome activation in the cerebral cortical regions, however no data has 
emerged on the cellular distribution of IL-1β induction and its main targets in 
the cerebellum. Therefore it would be of value to further evaluate this in animal 
models and cell cultures. 
 As inflammasome is activated in chronic alcohol model in the cerebellum, the 
timeline of its occurrence might be of interest, therefore acute gavage models 
could be of benefit. 
 To address whether HMGB1 is indeed a major harmful agent in the alcohol 
induced neuroinflammatory process, HMGB-1 silencing might be informative in 
in vivo and in vitro models. 
 HMGB1 pathway has been considered as a candidate for treatment for alcohol 
induced inflammatory changes. It is noteworthy to test siHMGB1 whether it is 
able to halt or reverse the inflammatory processes. 
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8. CONCLUSIONS 
 
Based on our animal model we could conclude the following: 
 Both acute and chronic alcohol intake impair intestinal barrier function; the 
increased serum endotoxin after acute alcohol binge is transient. 
 Increased serum endotoxin after chronic alcohol administration is associated 
with reduced Reg3b whereas acute alcohol administration induces Reg3b 
production. 
 Chronic alcohol intake induces inflammation in the gut-liver-brain axis, 
including NF-κB activation and TNFα production. 
 Chronic alcohol administration up-regulates and activates the NLRP3/ASC 
inflammasome leading to caspase-1 activation and IL-1β production in the liver 
and cerebellum in contrast to the proximal small intestine. 
 Chronic alcohol intake increases the levels of phosphorylated and acetylated 
forms of HMGB1 in the cerebellum. 
 Disruption of IL-1/IL-1R signaling by rIL-1Ra prevents alcohol-induced 
inflammasome activation, neuroinflammation and steatohepatitis by inhibiting 
inflammasome activation, IL-1β and TNFα production. 
 IL-1β amplifies neuroinflammation and steatohepatitis. 
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9. SUMMARY 
9.1. English summary 
Introduction: Alcohol-induced neuroinflammation and steatohepatitis is mediated by 
proinflammatory cytokines, including IL-1β. IL-1β production requires caspase-1 
activation by inflammasomes-multiprotein complexes that are assembled in response to 
danger signals. Hypothesis: We hypothesized that alcohol-induced inflammasome 
activation contributes to increased IL-1β in the gut-liver-brain axis. Methods: WT and 
TLR4-, NLRP3-, and ASC-deficient (KO) mice received an ethanol-containing or 
isocaloric control diet for 5 weeks, and some received the rIL-1Ra, anakinra, or saline 
treatment. Inflammasome activation, proinflammatory cytokines, endotoxin, and 
HMGB1 were measured in murine proximal intestine and cerebellum.  Results: 
Expression of inflammasome components (NLRP1, NLRP3, ASC) and 
proinflammatory cytokines (TNF-α, MCP-1) was increased in brains and partially in 
intestines of alcohol-fed compared to control mice. Increased caspase-1 activity and IL-
1β protein in ethanol-fed mice indicated inflammasome activation in the brain, in 
contrast to the intestine. TLR4 deficiency protected from TNF-α, MCP-1, and 
attenuated alcohol-induced IL-1β increases in the brain. The TLR4 ligand, LPS, was 
increased in the serum, but not in the cerebellum of alcohol-fed mice. We found up-
regulation of acetylated and phosphorylated HMGB1 and increased expression of the 
HMGB1 receptors (TLR2, TLR4, TLR9, RAGE) in alcohol-fed mice in the brain. 
NLRP3- or ASC-deficient mice were protected from caspase-1 activation and alcohol-
induced IL-1β increase in the brain. Furthermore, in vivo treatment with rIL-1Ra 
prevented alcohol-induced inflammasome activation and IL-1β, TNF-α induction in the 
brain, and prevented acetylated HMGB1 increase in the cerebellum. Conclusion: In 
conclusion, alcohol induces inflammation in the gut-liver-brain axis. Alcohol up-
regulates and activates the NLRP3/ASC inflammasome, leading to caspase-1 activation 
and IL-1β increase in the cerebellum and liver in contrast to the intestine. IL-1β 
amplifies neuroinflammation, and steatohepatitis. Disruption of IL-1/IL-1R signaling 
prevents alcohol-induced inflammasome activation, neuroinflammation and 
steatohepatitis. Increased levels of acetylated and phosphorylated HMGB1 may 
contribute to alcoholic neuroinflammation. 
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9.2. Magyar összefoglalás 
Bevezetés: Az alkohol okozta neuroinflammációt és steatohepatitist proinflammatorikus 
citokinek mediálják, mint pl. az IL-1β. Az IL-1β képzéséhez az inflammaszóma 
multiprotein-komplex általi kaszpáz-1 aktivációra van szükség. Az inflammaszóma 
összeszerelése vészjelekre adott válasz. Feltevés: Az alkohol okozta inflammaszóma 
aktiváció hozzájárul a magasabb IL-1β-hoz a bél-máj-agy tengelyen. Módszerek: vad 
típusú, TLR4-, NLRP3-, és ASC-hiányos (KO) egerek alkohol tartalmú vagy 
isokalorikus kontroll diétaát kaptak 5 héten át. Néhány állat rIL-1Ra, anakinra, vagy 
fiziológiás sóoldatot kapott. Inflammaszóma aktiváció, proinflammatorikus citokinek, 
endotoxin és HMGB1 mérése történt egér proximalis vékonybélben és cerebellumban. 
Eredmények: Inflammaszóma komponensek (NLRP1, NLRP3, ASC) és 
proinflammatorikus citokinek (TNF-α, MCP-1) expressziója megnövekedett az agyban 
és részben a bélben alkohol diétában részsülő egereknél összehasonlítva a kontrollal. A 
megnövekedett kaszpáz-1 aktivitás és IL-1β fehérje mennyisége alkohol diétában 
részesült egerekben az inflammaszóma aktivációjára utalt az agyban, ellentétben a 
béllel. A TLR4 hiánya meggátolta a TNF-α és MCP-1, valamint csökkentette az alkohol 
okozta IL-1β növekedést az agyban. A TLR4 ligand, LPS, magasabb volt az alkoholos 
egerek szérumában, de nem a cerebellumában. Alkohol diétán tartott egerek agyában 
magasabb az acetilált és foszforilált HMGB1 szintje, valamint az HMGB1 receptorok 
expressziója (TLR2, TLR4, TLR9, RAGE). Az NLRP3- vagy ASC-hiánya meggátolta a 
kaszpáz-1 aktivációt és az alkohol okozta IL-1β emelkedést az agyban. In vivo rIL-1Ra 
kezelés meggátolta az alkohol okozta inflammaszóma aktivációt, valamint az IL-1β és a 
TNF-α emelkedését az agyban, továbbá elmaradt az acetilált HMGB1 emelkedés a 
cerebellumban. Következtetések: Az alkohol gyulladást okoz a bél-máj-agy tengelyen. 
Az alkohol növeli és aktiválja az NLRP3/ASC inflammaszómát, mely kaszpáz-1 
aktiváción keresztül IL-1β növekedéshez vezet a cerebellumban és a májban, 
ellentétben a béllel. Az IL-1β felerősíti a neuroinflammációt és steatohepatitist. Az IL-
1/IL-1R jelátviteli útvonal gátlása megelőzi az alkohol okozta inflammaszóma 
aktivációt, a neuroinflammációt és steatohepatitist. A megnövekedett mennyiségű acetil 
és foszforilált HMGB1 hozzájárulhat az alkohol okozta neuroinflammációhoz. 
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